//
ID   XRDS_Hum              Reviewed;         511 AA.
AC   xx; ss; dd; dd; rr;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   16-JAN-2019, entry version 130.
DE   RecName: Full=Aprataxin and PNK-like factor;
DE            EC=4.2.99.18;
DE   AltName: Full=Apurinic-apyrimidinic endonuclease APLF;
DE   AltName: Full=PNK and APTX-like FHA domain-containing protein;
DE   AltName: Full=XRCC1-interacting protein 1;
GN   Name=APLF; Synonyms=C2orf13, PALF, XIP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
//
ID   APLF_HUMAN              Reviewed;         511 AA.
AC   Q8IW19; A8K476; Q53P47; Q53PB9; Q53QU0;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   16-JAN-2019, entry version 130.
DE   RecName: Full=Aprataxin and PNK-like factor;
DE            EC=4.2.99.18;
DE   AltName: Full=Apurinic-apyrimidinic endonuclease APLF;
DE   AltName: Full=PNK and APTX-like FHA domain-containing protein;
DE   AltName: Full=XRCC1-interacting protein 1;
GN   Name=APLF; Synonyms=C2orf13, PALF, XIP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION,
RP   POLY-ADP-RIBOSYLATION, AND INTERACTION WITH LIG4; PARP1; XRCC4 AND
RP   XRCC5.
RX   PubMed=17396150; DOI=10.1038/sj.emboj.7601663;
RA   Kanno S., Kuzuoka H., Sasao S., Hong Z., Lan L., Nakajima S.,
RA   Yasui A.;
RT   "A novel human AP endonuclease with conserved zinc-finger-like motifs
RT   involved in DNA strand break responses.";
RL   EMBO J. 26:2094-2103(2007).
RN   [5]
RP   SUBCELLULAR LOCATION, INTERACTION WITH XRCC1, PHOSPHORYLATION AT
RP   SER-116, AND MUTAGENESIS OF SER-116.
RX   PubMed=17507382; DOI=10.1074/jbc.C700060200;
RA   Bekker-Jensen S., Fugger K., Danielsen J.R., Gromova I., Sehested M.,
RA   Celis J., Bartek J., Lukas J., Mailand N.;
RT   "Human Xip1 (C2orf13) is a novel regulator of cellular responses to
RT   DNA strand breaks.";
RL   J. Biol. Chem. 282:19638-19643(2007).
RN   [6]
RP   FUNCTION, INTERACTION WITH PARP1; XRCC1; XRCC4 AND XRCC5, SUBCELLULAR
RP   LOCATION, AND PHOSPHORYLATION.
RX   PubMed=17353262; DOI=10.1128/MCB.02269-06;
RA   Iles N., Rulten S., El-Khamisy S.F., Caldecott K.W.;
RT   "APLF (C2orf13) is a novel human protein involved in the cellular
RT   response to chromosomal DNA strand breaks.";
RL   Mol. Cell. Biol. 27:3793-3803(2007).
RN   [7]
RP   INTERACTION WITH XRCC4, AND PHOSPHORYLATION.
RX   PubMed=18077224; DOI=10.1016/j.dnarep.2007.10.008;
RA   Macrae C.J., McCulloch R.D., Ylanko J., Durocher D., Koch C.A.;
RT   "APLF (C2orf13) facilitates nonhomologous end-joining and undergoes
RT   ATM-dependent hyperphosphorylation following ionizing radiation.";
RL   DNA Repair 7:292-302(2008).
RN   [8]
RP   SUBCELLULAR LOCATION, AND ADP-RIBOSE-BINDING.
RX   PubMed=18474613; DOI=10.1128/MCB.02243-07;
RA   Rulten S.L., Cortes-Ledesma F., Guo L., Iles N.J., Caldecott K.W.;
RT   "APLF (C2orf13) is a novel component of poly(ADP-ribose) signaling in
RT   mammalian cells.";
RL   Mol. Cell. Biol. 28:4620-4628(2008).
RN   [9]
RP   SUBCELLULAR LOCATION, DOMAIN PBZ-TYPE, POLY-ADP-RIBOSYLATION,
RP   ADP-RIBOSE-BINDING, AND MUTAGENESIS OF ARG-376; CYS-379; CYS-385;
RP   CYS-421 AND CYS-427.
RX   PubMed=18172500; DOI=10.1038/nature06420;
RA   Ahel I., Ahel D., Matsusaka T., Clark A.J., Pines J., Boulton S.J.,
RA   West S.C.;
RT   "Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint
RT   proteins.";
RL   Nature 451:81-85(2008).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND ADP-RIBOSE-BINDING.
RX   PubMed=21211721; DOI=10.1016/j.molcel.2010.12.006;
RA   Rulten S.L., Fisher A.E., Robert I., Zuma M.C., Rouleau M., Ju L.,
RA   Poirier G., Reina-San-Martin B., Caldecott K.W.;
RT   "PARP-3 and APLF function together to accelerate nonhomologous end-
RT   joining.";
RL   Mol. Cell 41:33-45(2011).
RN   [11]
RP   STRUCTURE BY NMR OF 368-451 ALONE AND IN COMPLEX WITH ADP-RIBOSE
RP   ANALOG, AND POLY-ADP-RIBOSE BINDING SITES.
RX   PubMed=20098424; DOI=10.1038/nsmb.1747;
RA   Eustermann S., Brockmann C., Mehrotra P.V., Yang J.C., Loakes D.,
RA   West S.C., Ahel I., Neuhaus D.;
RT   "Solution structures of the two PBZ domains from human APLF and their
RT   interaction with poly(ADP-ribose).";
RL   Nat. Struct. Mol. Biol. 17:241-243(2010).
RN   [12]
RP   STRUCTURE BY NMR OF 360-448, LINKER REGION, AND POLY-ADP-RIBOSE
RP   BINDING SITES.
RX   PubMed=20439749; DOI=10.1073/pnas.1000556107;
RA   Li G.Y., McCulloch R.D., Fenton A.L., Cheung M., Meng L., Ikura M.,
RA   Koch C.A.;
RT   "Structure and identification of ADP-ribose recognition motifs of APLF
RT   and role in the DNA damage response.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:9129-9134(2010).
CC   -!- FUNCTION: Nuclease involved in single-strand and double-strand DNA
CC       break repair (PubMed:17353262, PubMed:17396150). Recruited to
CC       sites of DNA damage through interaction with poly(ADP-ribose), a
CC       polymeric post-translational modification synthesized transiently
CC       at sites of chromosomal damage to accelerate DNA strand break
CC       repair reactions (PubMed:17353262, PubMed:17396150,
CC       PubMed:21211721). Displays apurinic-apyrimidinic (AP) endonuclease
CC       and 3'-5' exonuclease activities in vitro. Also able to introduce
CC       nicks at hydroxyuracil and other types of pyrimidine base damage
CC       (PubMed:17353262, PubMed:17396150). Together with PARP3, promotes
CC       the retention of the LIG4-XRCC4 complex on chromatin and
CC       accelerate DNA ligation during non-homologous end-joining (NHEJ)
CC       (PubMed:21211721). {ECO:0000269|PubMed:17353262,
CC       ECO:0000269|PubMed:17396150, ECO:0000269|PubMed:21211721}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=The C-O-P bond 3' to the apurinic or apyrimidinic site in
CC         DNA is broken by a beta-elimination reaction, leaving a 3'-
CC         terminal unsaturated sugar and a product with a terminal 5'-
CC         phosphate.; EC=4.2.99.18;
CC         Evidence={ECO:0000269|PubMed:17396150};
CC   -!- SUBUNIT: Interacts with LIG4, PARP1, XRCC1, XRCC4 and XRCC5.
CC       {ECO:0000269|PubMed:17353262, ECO:0000269|PubMed:17396150,
CC       ECO:0000269|PubMed:17507382, ECO:0000269|PubMed:18077224,
CC       ECO:0000269|PubMed:20098424}.
CC   -!- INTERACTION:
CC       Q53SE7:FLJ13057; NbExp=3; IntAct=EBI-1256044, EBI-10172181;
CC       P49917:LIG4; NbExp=2; IntAct=EBI-1256044, EBI-847896;
CC       P09874:PARP1; NbExp=7; IntAct=EBI-1256044, EBI-355676;
CC       P18887:XRCC1; NbExp=10; IntAct=EBI-1256044, EBI-947466;
CC       Q13426:XRCC4; NbExp=4; IntAct=EBI-1256044, EBI-717592;
CC       P13010:XRCC5; NbExp=13; IntAct=EBI-1256044, EBI-357997;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17353262,
CC       ECO:0000269|PubMed:17396150, ECO:0000269|PubMed:17507382}.
CC       Chromosome {ECO:0000269|PubMed:18172500,
CC       ECO:0000269|PubMed:18474613, ECO:0000269|PubMed:21211721}.
CC       Cytoplasm, cytosol {ECO:0000269|PubMed:17353262}. Note=Localizes
CC       to DNA damage sites (PubMed:18474613, PubMed:18172500,
CC       PubMed:21211721). Accumulates at single-strand breaks and double-
CC       strand breaks via the PBZ-type zinc fingers (PubMed:18172500).
CC       {ECO:0000269|PubMed:18172500, ECO:0000269|PubMed:18474613,
CC       ECO:0000269|PubMed:21211721}.
CC   -!- DOMAIN: The PBZ-type zinc fingers (also named CYR) mediate non-
CC       covalent poly(ADP-ribose)-binding. Poly(ADP-ribose)-binding is
CC       dependent on the presence of zinc and promotes its recruitment to
CC       DNA damage sites. {ECO:0000269|PubMed:18172500}.
CC   -!- DOMAIN: The FHA-like domain mediates interaction with XRCC1 and
CC       XRCC4. {ECO:0000269|PubMed:18172500}.
CC   -!- PTM: Poly-ADP-ribosylated. In addition to binding non covalently
CC       poly(ADP-ribose) via its PBZ-type zinc fingers, the protein is
CC       also covalently poly-ADP-ribosylated by PARP1.
CC       {ECO:0000269|PubMed:17396150, ECO:0000269|PubMed:18172500}.
CC   -!- PTM: Phosphorylated in an ATM-dependent manner upon double-strand
CC       DNA break. {ECO:0000269|PubMed:17353262,
CC       ECO:0000269|PubMed:17507382, ECO:0000269|PubMed:18077224}.
CC   -!- SIMILARITY: Belongs to the APLF family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAY14945.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; AK290841; BAF83530.1; -; mRNA.
DR   EMBL; AC105054; AAY24113.1; -; Genomic_DNA.
DR   EMBL; AC127383; AAY24008.1; -; Genomic_DNA.
DR   EMBL; AC130709; AAY14945.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BC041144; AAH41144.1; -; mRNA.
DR   CCDS; CCDS1888.1; -.
DR   RefSeq; NP_775816.1; NM_173545.2.
DR   UniGene; Hs.720369; -.
DR   PDB; 2KQB; NMR; -; A=368-451.
DR   PDB; 2KQC; NMR; -; A=368-451.
DR   PDB; 2KQD; NMR; -; A=368-451.
DR   PDB; 2KQE; NMR; -; A=368-451.
DR   PDB; 2KUO; NMR; -; A=360-448.
DR   PDB; 5E50; X-ray; 1.38 A; A/B=1-105.
DR   PDB; 5W7W; X-ray; 1.35 A; A/T=1-105.
DR   PDB; 5W7X; X-ray; 2.00 A; A/B/C/D=1-105.
DR   PDB; 5W7Y; X-ray; 2.10 A; A/B=1-105.
DR   PDB; 6ERF; X-ray; 3.01 A; Q/R/S/T=174-191.
DR   PDBsum; 2KQB; -.
DR   PDBsum; 2KQC; -.
DR   PDBsum; 2KQD; -.
DR   PDBsum; 2KQE; -.
DR   PDBsum; 2KUO; -.
DR   PDBsum; 5E50; -.
DR   PDBsum; 5W7W; -.
DR   PDBsum; 5W7X; -.
DR   PDBsum; 5W7Y; -.
DR   PDBsum; 6ERF; -.
DR   ProteinModelPortal; Q8IW19; -.
DR   SMR; Q8IW19; -.
DR   BioGrid; 128334; 33.
DR   DIP; DIP-39136N; -.
DR   IntAct; Q8IW19; 15.
DR   MINT; Q8IW19; -.
DR   STRING; 9606.ENSP00000307004; -.
DR   iPTMnet; Q8IW19; -.
DR   PhosphoSitePlus; Q8IW19; -.
DR   BioMuta; APLF; -.
DR   DMDM; 73619699; -.
DR   EPD; Q8IW19; -.
DR   jPOST; Q8IW19; -.
DR   MaxQB; Q8IW19; -.
DR   PaxDb; Q8IW19; -.
DR   PeptideAtlas; Q8IW19; -.
DR   PRIDE; Q8IW19; -.
DR   ProteomicsDB; 70796; -.
DR   Ensembl; ENST00000303795; ENSP00000307004; ENSG00000169621.
DR   GeneID; 200558; -.
DR   KEGG; hsa:200558; -.
DR   UCSC; uc002sep.4; human.
DR   CTD; 200558; -.
DR   DisGeNET; 200558; -.
DR   EuPathDB; HostDB:ENSG00000169621.9; -.
DR   GeneCards; APLF; -.
DR   HGNC; HGNC:28724; APLF.
DR   HPA; HPA034642; -.
DR   HPA; HPA034643; -.
DR   MIM; 611035; gene.
DR   neXtProt; NX_Q8IW19; -.
DR   OpenTargets; ENSG00000169621; -.
DR   PharmGKB; PA164715842; -.
DR   eggNOG; ENOG410IGNB; Eukaryota.
DR   eggNOG; ENOG41126IA; LUCA.
DR   GeneTree; ENSGT00390000010591; -.
DR   HOGENOM; HOG000033995; -.
DR   HOVERGEN; HBG095728; -.
DR   InParanoid; Q8IW19; -.
DR   KO; K13295; -.
DR   OrthoDB; 1606181at2759; -.
DR   PhylomeDB; Q8IW19; -.
DR   TreeFam; TF326160; -.
DR   ChiTaRS; APLF; human.
DR   EvolutionaryTrace; Q8IW19; -.
DR   GenomeRNAi; 200558; -.
DR   PRO; PR:Q8IW19; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000169621; Expressed in 116 organ(s), highest expression level in corpus callosum.
DR   CleanEx; HS_APLF; -.
DR   ExpressionAtlas; Q8IW19; baseline and differential.
DR   Genevisible; Q8IW19; HS.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0035861; C:site of double-strand break; IDA:MGI.
DR   GO; GO:0008408; F:3'-5' exonuclease activity; IDA:UniProtKB.
DR   GO; GO:0140078; F:class I DNA-(apurinic or apyrimidinic site) endonuclease activity; IEA:UniProtKB-EC.
DR   GO; GO:0003906; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; IDA:UniProtKB.
DR   GO; GO:0004520; F:endodeoxyribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000166; F:nucleotide binding; IDA:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0006302; P:double-strand break repair; IMP:UniProtKB.
DR   GO; GO:0051106; P:positive regulation of DNA ligation; IGI:MGI.
DR   GO; GO:0045191; P:regulation of isotype switching; IEA:Ensembl.
DR   GO; GO:0000012; P:single strand break repair; IMP:UniProtKB.
DR   CDD; cd00060; FHA; 1.
DR   InterPro; IPR039253; APLF.
DR   InterPro; IPR019406; APLF_PBZ.
DR   InterPro; IPR000253; FHA_dom.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   PANTHER; PTHR21315; PTHR21315; 1.
DR   Pfam; PF10283; zf-CCHH; 2.
DR   SUPFAM; SSF49879; SSF49879; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Chromosome; Coiled coil;
KW   Complete proteome; Cytoplasm; DNA damage; DNA repair; Lyase;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Zinc; Zinc-finger.
FT   CHAIN         1    511       Aprataxin and PNK-like factor.
FT                                /FTId=PRO_0000089342.
FT   DOMAIN        1    108       FHA-like.
FT   ZN_FING     377    398       PBZ-type 1.
FT   ZN_FING     419    440       PBZ-type 2.
FT   REGION      406    416       Flexible linker.
FT   COILED      487    511       {ECO:0000255}.
FT   BINDING     376    376       Poly-ADP-ribose.
FT                                {ECO:0000269|PubMed:18172500}.
FT   BINDING     381    381       Poly-ADP-ribose.
FT                                {ECO:0000269|PubMed:18172500}.
FT   BINDING     386    386       Poly-ADP-ribose.
FT                                {ECO:0000269|PubMed:18172500}.
FT   BINDING     387    387       Poly-ADP-ribose.
FT                                {ECO:0000269|PubMed:18172500}.
FT   BINDING     423    423       Poly-ADP-ribose.
FT                                {ECO:0000269|PubMed:18172500}.
FT   BINDING     428    428       Poly-ADP-ribose.
FT                                {ECO:0000269|PubMed:18172500}.
FT   BINDING     429    429       Poly-ADP-ribose.
FT                                {ECO:0000269|PubMed:18172500}.
FT   MOD_RES     116    116       Phosphoserine; by ATM.
FT                                {ECO:0000269|PubMed:17507382}.
FT   MOD_RES     149    149       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D842}.
FT   VARIANT     100    100       I -> V (in dbSNP:rs11902811).
FT                                /FTId=VAR_032299.
FT   VARIANT     224    224       S -> T (in dbSNP:rs35002937).
FT                                /FTId=VAR_061557.
FT   VARIANT     336    336       L -> F (in dbSNP:rs13404469).
FT                                /FTId=VAR_032300.
FT   MUTAGEN     116    116       S->A: Decreases phosphorylation by ATM.
FT                                {ECO:0000269|PubMed:17507382}.
FT   MUTAGEN     376    376       R->A: Abolishes poly(ADP-ribose)-binding
FT                                and poly-ADP-ribosylation by PARP1; when
FT                                associated with A-421 and A-427.
FT                                {ECO:0000269|PubMed:18172500}.
FT   MUTAGEN     379    379       C->A: Abolishes poly(ADP-ribose)-binding
FT                                and poly-ADP-ribosylation by PARP1; when
FT                                associated with A-385; A-421 and A-427.
FT                                {ECO:0000269|PubMed:18172500}.
FT   MUTAGEN     385    385       C->A: Abolishes poly(ADP-ribose)-binding
FT                                and poly-ADP-ribosylation by PARP1; when
FT                                associated with A-379; A-421 and A-427.
FT                                {ECO:0000269|PubMed:18172500}.
FT   MUTAGEN     421    421       C->A: Abolishes poly(ADP-ribose)-binding
FT                                and poly-ADP-ribosylation by PARP1; when
FT                                associated with A-379; A-385 and A-427.
FT                                Abolishes poly(ADP-ribose)-binding and
FT                                poly-ADP-ribosylation by PARP1; when
FT                                associated with A-376 and A-427.
FT                                {ECO:0000269|PubMed:18172500}.
FT   MUTAGEN     427    427       C->A: Abolishes poly(ADP-ribose)-binding
FT                                and poly-ADP-ribosylation by PARP1; when
FT                                associated with A-379; A-385 and A-421.
FT                                Abolishes poly(ADP-ribose)-binding and
FT                                poly-ADP-ribosylation by PARP1; when
FT                                associated with A-376 and A-421.
FT                                {ECO:0000269|PubMed:18172500}.
FT   CONFLICT    313    313       Missing (in Ref. 1; BAF83530).
FT                                {ECO:0000305}.
FT   STRAND        4      9       {ECO:0000244|PDB:5W7W}.
FT   STRAND       16     18       {ECO:0000244|PDB:5W7W}.
FT   STRAND       20     28       {ECO:0000244|PDB:5W7W}.
FT   TURN         29     32       {ECO:0000244|PDB:5W7W}.
FT   STRAND       43     48       {ECO:0000244|PDB:5W7W}.
FT   STRAND       51     56       {ECO:0000244|PDB:5W7W}.
FT   STRAND       58     60       {ECO:0000244|PDB:5W7W}.
FT   STRAND       63     65       {ECO:0000244|PDB:5W7W}.
FT   STRAND       81     83       {ECO:0000244|PDB:5E50}.
FT   STRAND       88     92       {ECO:0000244|PDB:5W7W}.
FT   STRAND       95    102       {ECO:0000244|PDB:5W7W}.
FT   TURN        188    190       {ECO:0000244|PDB:6ERF}.
FT   STRAND      371    374       {ECO:0000244|PDB:2KQB}.
FT   TURN        380    383       {ECO:0000244|PDB:2KQB}.
FT   HELIX       392    395       {ECO:0000244|PDB:2KQB}.
FT   TURN        412    414       {ECO:0000244|PDB:2KQB}.
FT   HELIX       424    426       {ECO:0000244|PDB:2KQC}.
FT   HELIX       432    437       {ECO:0000244|PDB:2KQC}.
SQ   SEQUENCE   511 AA;  56956 MW;  CBBF0096843298DA CRC64;
     MSGGFELQPR DGGPRVALAP GETVIGRGPL LGITDKRVSR RHAILEVAGG QLRIKPIHTN
     PCFYQSSEKS QLLPLKPNLW CYLNPGDSFS LLVDKYIFRI LSIPSEVEMQ CTLRNSQVLD
     EDNILNETPK SPVINLPHET TGASQLEGST EIAKTQMTPT NSVSFLGENR DCNKQQPILA
     ERKRILPTWM LAEHLSDQNL SVPAISGGNV IQGSGKEEIC KDKSQLNTTQ QGRRQLISSG
     SSENTSAEQD TGEECKNTDQ EESTISSKEM PQSFSAITLS NTEMNNIKTN AQRNKLPIEE
     LGKVSKHKIA TKRTPHKEDE AMSCSENCSS AQGDSLQDES QGSHSESSSN PSNPETLHAK
     ATDSVLQGSE GNKVKRTSCM YGANCYRKNP VHFQHFSHPG DSDYGGVQIV GQDETDDRPE
     CPYGPSCYRK NPQHKIEYRH NTLPVRNVLD EDNDNVGQPN EYDLNDSFLD DEEEDYEPTD
     EDSDWEPGKE DEEKEDVEEL LKEAKRFMKR K
//
ID   APTX_HUMAN              Reviewed;         356 AA.
AC   Q7Z2E3; A8MTN4; D3DRK9; D3DRL0; Q0P662; Q5T781; Q5T782; Q5T784;
AC   Q6JV81; Q6JV82; Q6JV85; Q7Z2F3; Q7Z336; Q7Z5R5; Q7Z6V7; Q7Z6V8;
AC   Q9NXM5;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 2.
DT   10-MAY-2017, entry version 149.
DE   RecName: Full=Aprataxin;
DE            EC=3.-.-.-;
DE   AltName: Full=Forkhead-associated domain histidine triad-like protein;
DE            Short=FHA-HIT;
GN   Name=APTX; Synonyms=AXA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 7; 12 AND 13), ALTERNATIVE
RP   SPLICING, AND SUBCELLULAR LOCATION.
RX   PubMed=15276230; DOI=10.1016/j.neulet.2004.05.034;
RA   Hirano M., Nishiwaki T., Kariya S., Furiya Y., Kawahara M., Ueno S.;
RT   "Novel splice variants increase molecular diversity of aprataxin, the
RT   gene responsible for early-onset ataxia with ocular motor apraxia and
RT   hypoalbuminemia.";
RL   Neurosci. Lett. 366:120-125(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Huang C.-H.;
RT   "Identification of FHA-HIT as a novel nuclear protein involved in
RT   cell-cycle regulation.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6; 7; 8 AND 10).
RC   TISSUE=Hypothalamus, Kidney, Lung adenocarcinoma, Lymphoma, Melanoma,
RC   Muscle, Retinoblastoma, Skin, and Testis;
RA   Chen Y., Huang C.-H.;
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 11).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 9).
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 4 AND 7).
RC   TISSUE=Brain, Lung, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-261 (ISOFORMS 2; 4; 5 AND 7).
RC   TISSUE=Brain;
RA   Hellenbroich Y., Habeck M.;
RT   "Mutations in the APTX gene.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   TISSUE SPECIFICITY, AND VARIANTS AOA LEU-220 AND GLY-277.
RX   PubMed=11586299; DOI=10.1038/ng1001-184;
RA   Date H., Onodera O., Tanaka H., Iwabuchi K., Uekawa K., Igarashi S.,
RA   Koike R., Hiroi T., Yuasa T., Awaya Y., Sakai T., Takahashi T.,
RA   Nagatomo H., Sekijima Y., Kawachi I., Takiyama Y., Nishizawa M.,
RA   Fukuhara N., Saito K., Sugano S., Tsuji S.;
RT   "Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is
RT   caused by mutations in a new HIT superfamily gene.";
RL   Nat. Genet. 29:184-188(2001).
RN   [11]
RP   ALTERNATIVE SPLICING, TISSUE SPECIFICITY, AND VARIANTS AOA HIS-213 AND
RP   LEU-220.
RX   PubMed=11586300; DOI=10.1038/ng1001-189;
RA   Moreira M.-C., Barbot C., Tachi N., Kozuka N., Uchida E., Gibson T.,
RA   Mendonca P., Costa M., Barros J., Yanagisawa T., Watanabe M.,
RA   Ikeda Y., Aoki M., Nagata T., Coutinho P., Sequeiros J., Koenig M.;
RT   "The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-
RT   finger protein aprataxin.";
RL   Nat. Genet. 29:189-193(2001).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION
RP   WITH XRCC1.
RX   PubMed=14755728; DOI=10.1002/ana.10808;
RA   Sano Y., Date H., Igarashi S., Onodera O., Oyake M., Takahashi T.,
RA   Hayashi S., Morimatsu M., Takahashi H., Makifuchi T., Fukuhara N.,
RA   Tsuji S.;
RT   "Aprataxin, the causative protein for EAOH is a nuclear protein with a
RT   potential role as a DNA repair protein.";
RL   Ann. Neurol. 55:241-249(2004).
RN   [13]
RP   INTERACTION WITH XRCC1 AND XRCC4, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF ARG-43.
RX   PubMed=15380105; DOI=10.1016/j.dnarep.2004.06.017;
RA   Clements P.M., Breslin C., Deeks E.D., Byrd P.J., Ju L.,
RA   Bieganowski P., Brenner C., Moreira M.-C., Taylor A.M.R.,
RA   Caldecott K.W.;
RT   "The ataxia-oculomotor apraxia 1 gene product has a role distinct from
RT   ATM and interacts with the DNA strand break repair proteins XRCC1 and
RT   XRCC4.";
RL   DNA Repair 3:1493-1502(2004).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH XRCC1; ADPRT;
RP   TP53 AND NCL.
RX   PubMed=15044383; DOI=10.1093/hmg/ddh122;
RA   Gueven N., Becherel O.J., Kijas A.W., Chen P., Howe O., Rudolph J.H.,
RA   Gatti R., Date H., Onodera O., Taucher-Scholz G., Lavin M.F.;
RT   "Aprataxin, a novel protein that protects against genotoxic stress.";
RL   Hum. Mol. Genet. 13:1081-1093(2004).
RN   [15]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH XRCC1 AND NCL.
RX   PubMed=16777843; DOI=10.1093/hmg/ddl149;
RA   Becherel O.J., Gueven N., Birrell G.W., Schreiber V., Suraweera A.,
RA   Jakob B., Taucher-Scholz G., Lavin M.F.;
RT   "Nucleolar localization of aprataxin is dependent on interaction with
RT   nucleolin and on active ribosomal DNA transcription.";
RL   Hum. Mol. Genet. 15:2239-2249(2006).
RN   [16]
RP   FUNCTION, DNA-BINDING, AND CHARACTERIZATION OF VARIANT GLY-277.
RX   PubMed=16547001; DOI=10.1074/jbc.M507946200;
RA   Kijas A.W., Harris J.L., Harris J.M., Lavin M.F.;
RT   "Aprataxin forms a discrete branch in the HIT (histidine triad)
RT   superfamily of proteins with both DNA/RNA binding and nucleotide
RT   hydrolase activities.";
RL   J. Biol. Chem. 281:13939-13948(2006).
RN   [17]
RP   FUNCTION, AND MUTAGENESIS OF HIS-274.
RX   PubMed=16964241; DOI=10.1038/nature05164;
RA   Ahel I., Rass U., El-Khamisy S.F., Katyal S., Clements P.M.,
RA   McKinnon P.J., Caldecott K.W., West S.C.;
RT   "The neurodegenerative disease protein aprataxin resolves abortive DNA
RT   ligation intermediates.";
RL   Nature 443:713-716(2006).
RN   [18]
RP   FUNCTION, AND MUTAGENESIS OF HIS-274; CYS-333 AND CYS-336.
RX   PubMed=17276982; DOI=10.1074/jbc.M611489200;
RA   Rass U., Ahel I., West S.C.;
RT   "Actions of aprataxin in multiple DNA repair pathways.";
RL   J. Biol. Chem. 282:9469-9474(2007).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 15-116, SUBCELLULAR
RP   LOCATION, INTERACTION WITH MDC1, AND MUTAGENESIS OF ARG-43 AND LYS-52.
RX   PubMed=20008512; DOI=10.1093/nar/gkp1149;
RA   Becherel O.J., Jakob B., Cherry A.L., Gueven N., Fusser M.,
RA   Kijas A.W., Peng C., Katyal S., McKinnon P.J., Chen J., Epe B.,
RA   Smerdon S.J., Taucher-Scholz G., Lavin M.F.;
RT   "CK2 phosphorylation-dependent interaction between aprataxin and MDC1
RT   in the DNA damage response.";
RL   Nucleic Acids Res. 38:1489-1503(2010).
RN   [22]
RP   VARIANT AOA ARG-215.
RX   PubMed=12196655; DOI=10.1212/WNL.59.4.590;
RA   Shimazaki H., Takiyama Y., Sakoe K., Ikeguchi K., Niijima K.,
RA   Kaneko J., Namekawa M., Ogawa T., Date H., Tsuji S., Nakano I.,
RA   Nishizawa M.;
RT   "Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the
RT   aprataxin gene mutations.";
RL   Neurology 59:590-595(2002).
RN   [23]
RP   VARIANT AOA GLN-211.
RX   PubMed=12629250; DOI=10.1212/01.WNL.0000048562.88536.A4;
RA   Tranchant C., Fleury M., Moreira M.-C., Koenig M., Warter J.-M.;
RT   "Phenotypic variability of aprataxin gene mutations.";
RL   Neurology 60:868-870(2003).
RN   [24]
RP   VARIANTS AOA VAL-212; GLY-277 AND ARG-293.
RX   PubMed=14506070; DOI=10.1093/brain/awg283;
RA   Le Ber I., Moreira M.-C., Rivaud-Pechoux S., Chamayou C., Ochsner F.,
RA   Kuntzer T., Tardieu M., Saied G., Habert M.-O., Demarquay G.,
RA   Tannier C., Beis J.-M., Brice A., Koenig M., Duerr A.;
RT   "Cerebellar ataxia with oculomotor apRAxia type 1: clinical and
RT   genetic studies.";
RL   Brain 126:2761-2772(2003).
RN   [25]
RP   VARIANT AOA PRO-237.
RX   PubMed=15852392; DOI=10.1002/ana.20463;
RA   Criscuolo C., Mancini P., Menchise V., Sacca F., De Michele G.,
RA   Banfi S., Filla A.;
RT   "Very late onset in ataxia oculomotor apraxia type I.";
RL   Ann. Neurol. 57:777-777(2005).
RN   [26]
RP   INVOLVEMENT IN AOA.
RX   PubMed=15699391; DOI=10.1212/01.WNL.0000150588.75281.58;
RA   Quinzii C.M., Kattah A.G., Naini A., Akman H.O., Mootha V.K.,
RA   DiMauro S., Hirano M.;
RT   "Coenzyme Q deficiency and cerebellar ataxia associated with an
RT   aprataxin mutation.";
RL   Neurology 64:539-541(2005).
CC   -!- FUNCTION: DNA-binding protein involved in single-strand DNA break
CC       repair, double-strand DNA break repair and base excision repair.
CC       Resolves abortive DNA ligation intermediates formed either at base
CC       excision sites, or when DNA ligases attempt to repair non-
CC       ligatable breaks induced by reactive oxygen species. Catalyzes the
CC       release of adenylate groups covalently linked to 5'-phosphate
CC       termini, resulting in the production of 5'-phosphate termini that
CC       can be efficiently rejoined. Also able to hydrolyze adenosine 5'-
CC       monophosphoramidate (AMP-NH(2)) and diadenosine tetraphosphate
CC       (AppppA), but with lower catalytic activity.
CC       {ECO:0000269|PubMed:14755728, ECO:0000269|PubMed:15044383,
CC       ECO:0000269|PubMed:16547001, ECO:0000269|PubMed:16964241,
CC       ECO:0000269|PubMed:17276982}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=18 uM for AppppA;
CC         KM=837.5 uM for AMP-NH(2);
CC   -!- SUBUNIT: Interacts with single-strand break repair proteins XRCC1,
CC       XRCC4, ADPRT and p53/TP53. Interacts with NCL. Interacts (via FHA-
CC       like domain) with MDC1 (phosphorylated).
CC       {ECO:0000269|PubMed:14755728, ECO:0000269|PubMed:15044383,
CC       ECO:0000269|PubMed:15380105, ECO:0000269|PubMed:16777843,
CC       ECO:0000269|PubMed:20008512}.
CC   -!- INTERACTION:
CC       P09874:PARP1; NbExp=8; IntAct=EBI-847814, EBI-355676;
CC       Q8ND90:PNMA1; NbExp=3; IntAct=EBI-12298187, EBI-302345;
CC       P18887:XRCC1; NbExp=11; IntAct=EBI-847814, EBI-947466;
CC       Q13426:XRCC4; NbExp=3; IntAct=EBI-847814, EBI-717592;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm. Nucleus, nucleolus.
CC       Note=Upon genotoxic stress, colocalizes with XRCC1 at sites of DNA
CC       damage. Colocalizes with MDC1 at sites of DNA double-strand
CC       breaks. Interaction with NCL is required for nucleolar
CC       localization.
CC   -!- SUBCELLULAR LOCATION: Isoform 12: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=13;
CC       Name=1; Synonyms=Long;
CC         IsoId=Q7Z2E3-1; Sequence=Displayed;
CC         Note=Major form.;
CC       Name=2; Synonyms=Short;
CC         IsoId=Q7Z2E3-2; Sequence=VSP_010535;
CC         Note=Minor form.;
CC       Name=3;
CC         IsoId=Q7Z2E3-3; Sequence=VSP_010539;
CC         Note=May be an aberrant isoform present in cancer cell lines.;
CC       Name=4;
CC         IsoId=Q7Z2E3-4; Sequence=VSP_010536;
CC         Note=May be an aberrant isoform present in cancer cell lines.;
CC       Name=5;
CC         IsoId=Q7Z2E3-5; Sequence=VSP_010537, VSP_010538;
CC         Note=May be an aberrant isoform present in cancer cell lines.;
CC       Name=6;
CC         IsoId=Q7Z2E3-6; Sequence=VSP_010534, VSP_010541;
CC         Note=May be an aberrant isoform present in cancer cell lines.;
CC       Name=7;
CC         IsoId=Q7Z2E3-7; Sequence=VSP_010537;
CC       Name=8;
CC         IsoId=Q7Z2E3-8; Sequence=VSP_010540;
CC         Note=May be an aberrant isoform present in cancer cell lines.;
CC       Name=9;
CC         IsoId=Q7Z2E3-9; Sequence=VSP_010537, VSP_010541;
CC         Note=No experimental confirmation available.;
CC       Name=10;
CC         IsoId=Q7Z2E3-10; Sequence=VSP_010538;
CC         Note=May be an aberrant isoform present in cancer cell lines.;
CC       Name=11;
CC         IsoId=Q7Z2E3-11; Sequence=VSP_010541;
CC         Note=No experimental confirmation available.;
CC       Name=12; Synonyms=LP2, LP2E5, LP2P3, LP2P3E5;
CC         IsoId=Q7Z2E3-12; Sequence=VSP_010537, VSP_044091, VSP_044092;
CC       Name=13; Synonyms=LE5;
CC         IsoId=Q7Z2E3-13; Sequence=VSP_010537, VSP_044093;
CC   -!- TISSUE SPECIFICITY: Widely expressed. In brain, it is expressed in
CC       the posterior cortex, cerebellum, hippocampus and olfactory bulb.
CC       Isoform 1 is highly expressed in the cerebral cortex and
CC       cerebellum, compared to isoform 2. {ECO:0000269|PubMed:11586299,
CC       ECO:0000269|PubMed:11586300, ECO:0000269|PubMed:14755728}.
CC   -!- DOMAIN: The histidine triad, also called HIT motif, forms part of
CC       the binding loop for the alpha-phosphate of purine mononucleotide.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The FHA-like domain mediates interaction with NCL; XRCC1
CC       and XRCC4.
CC   -!- DOMAIN: The HIT domain is required for enzymatic activity.
CC   -!- DOMAIN: The C2H2-type zinc finger mediates DNA-binding.
CC   -!- DISEASE: Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920]: An
CC       autosomal recessive syndrome characterized by early-onset
CC       cerebellar ataxia, oculomotor apraxia, early areflexia and late
CC       peripheral neuropathy. {ECO:0000269|PubMed:11586299,
CC       ECO:0000269|PubMed:11586300, ECO:0000269|PubMed:12196655,
CC       ECO:0000269|PubMed:12629250, ECO:0000269|PubMed:14506070,
CC       ECO:0000269|PubMed:15699391, ECO:0000269|PubMed:15852392}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY302067; AAQ74130.1; -; mRNA.
DR   EMBL; AY302068; AAQ74131.1; -; mRNA.
DR   EMBL; AY302070; AAQ74133.1; -; mRNA.
DR   EMBL; AY302071; AAQ74134.1; -; mRNA.
DR   EMBL; AY302072; AAQ74135.1; -; mRNA.
DR   EMBL; AY302074; AAQ74137.1; -; mRNA.
DR   EMBL; AY040777; AAK91768.1; -; mRNA.
DR   EMBL; AY208829; AAP86319.1; -; mRNA.
DR   EMBL; AY208830; AAP86320.1; -; mRNA.
DR   EMBL; AY208831; AAP86321.1; -; mRNA.
DR   EMBL; AY208832; AAP86322.1; -; mRNA.
DR   EMBL; AY208833; AAP86323.1; -; mRNA.
DR   EMBL; AY208834; AAP86324.1; -; mRNA.
DR   EMBL; AY208835; AAP86325.1; -; mRNA.
DR   EMBL; AY208836; AAP86326.1; -; mRNA.
DR   EMBL; AY208837; AAP86327.1; -; mRNA.
DR   EMBL; AY208838; AAP86328.1; -; mRNA.
DR   EMBL; AY208839; AAP86329.1; -; mRNA.
DR   EMBL; AY208840; AAP86330.1; -; mRNA.
DR   EMBL; AY208841; AAP86331.1; -; mRNA.
DR   EMBL; AY208842; AAP86332.1; -; mRNA.
DR   EMBL; AK000164; BAA90985.1; -; mRNA.
DR   EMBL; AK055672; BAG51552.1; -; mRNA.
DR   EMBL; BX538161; CAD98041.1; -; mRNA.
DR   EMBL; AL162590; CAI15549.1; -; Genomic_DNA.
DR   EMBL; AL353717; CAI15549.1; JOINED; Genomic_DNA.
DR   EMBL; AL162590; CAI15551.1; -; Genomic_DNA.
DR   EMBL; AL353717; CAI15551.1; JOINED; Genomic_DNA.
DR   EMBL; AL353717; CAI15728.1; -; Genomic_DNA.
DR   EMBL; AL162590; CAI15728.1; JOINED; Genomic_DNA.
DR   EMBL; AL353717; CAI15730.1; -; Genomic_DNA.
DR   EMBL; AL162590; CAI15730.1; JOINED; Genomic_DNA.
DR   EMBL; AL353717; CAI15734.1; -; Genomic_DNA.
DR   EMBL; AL353717; CAI15735.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58530.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58529.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58531.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58532.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58534.1; -; Genomic_DNA.
DR   EMBL; CH471071; EAW58535.1; -; Genomic_DNA.
DR   EMBL; BC001628; AAH01628.1; -; mRNA.
DR   EMBL; BC032650; AAH32650.1; -; mRNA.
DR   EMBL; BC104881; AAI04882.1; -; mRNA.
DR   EMBL; AJ565850; CAD92454.1; -; mRNA.
DR   EMBL; AJ565851; CAD92455.1; -; mRNA.
DR   EMBL; AJ565852; CAD92456.1; -; mRNA.
DR   EMBL; AJ565853; CAD92457.1; -; mRNA.
DR   EMBL; AJ565854; CAD92458.1; -; mRNA.
DR   EMBL; AJ565855; CAD92459.1; -; mRNA.
DR   EMBL; AJ575566; CAE01427.1; -; mRNA.
DR   CCDS; CCDS47956.1; -. [Q7Z2E3-7]
DR   CCDS; CCDS56568.1; -. [Q7Z2E3-10]
DR   CCDS; CCDS6532.1; -. [Q7Z2E3-11]
DR   CCDS; CCDS75827.1; -. [Q7Z2E3-5]
DR   RefSeq; NP_001182177.1; NM_001195248.1. [Q7Z2E3-1]
DR   RefSeq; NP_001182178.1; NM_001195249.1. [Q7Z2E3-7]
DR   RefSeq; NP_001182179.1; NM_001195250.1. [Q7Z2E3-10]
DR   RefSeq; NP_001182180.1; NM_001195251.1. [Q7Z2E3-9]
DR   RefSeq; NP_001182181.1; NM_001195252.1. [Q7Z2E3-3]
DR   RefSeq; NP_001182183.1; NM_001195254.1. [Q7Z2E3-5]
DR   RefSeq; NP_778239.1; NM_175069.2. [Q7Z2E3-11]
DR   RefSeq; NP_778243.1; NM_175073.2. [Q7Z2E3-7]
DR   RefSeq; XP_006716854.1; XM_006716791.3. [Q7Z2E3-7]
DR   RefSeq; XP_006716855.1; XM_006716792.2. [Q7Z2E3-4]
DR   RefSeq; XP_011516240.1; XM_011517938.1. [Q7Z2E3-4]
DR   RefSeq; XP_011516241.1; XM_011517939.2. [Q7Z2E3-4]
DR   RefSeq; XP_016870326.1; XM_017014837.1. [Q7Z2E3-5]
DR   UniGene; Hs.20158; -.
DR   PDB; 3KT9; X-ray; 1.65 A; A=15-116.
DR   PDB; 4NDF; X-ray; 1.94 A; A/B=179-356.
DR   PDB; 4NDG; X-ray; 2.54 A; A/B=179-356.
DR   PDB; 4NDH; X-ray; 1.85 A; A/B=179-356.
DR   PDB; 4NDI; X-ray; 1.90 A; A/B=179-356.
DR   PDBsum; 3KT9; -.
DR   PDBsum; 4NDF; -.
DR   PDBsum; 4NDG; -.
DR   PDBsum; 4NDH; -.
DR   PDBsum; 4NDI; -.
DR   ProteinModelPortal; Q7Z2E3; -.
DR   SMR; Q7Z2E3; -.
DR   BioGrid; 120191; 26.
DR   IntAct; Q7Z2E3; 22.
DR   MINT; MINT-1205251; -.
DR   STRING; 9606.ENSP00000369141; -.
DR   iPTMnet; Q7Z2E3; -.
DR   PhosphoSitePlus; Q7Z2E3; -.
DR   BioMuta; APTX; -.
DR   DMDM; 48428038; -.
DR   EPD; Q7Z2E3; -.
DR   MaxQB; Q7Z2E3; -.
DR   PaxDb; Q7Z2E3; -.
DR   PeptideAtlas; Q7Z2E3; -.
DR   PRIDE; Q7Z2E3; -.
DR   TopDownProteomics; Q7Z2E3-5; -. [Q7Z2E3-5]
DR   DNASU; 54840; -.
DR   Ensembl; ENST00000309615; ENSP00000311547; ENSG00000137074. [Q7Z2E3-5]
DR   Ensembl; ENST00000379817; ENSP00000369145; ENSG00000137074. [Q7Z2E3-7]
DR   Ensembl; ENST00000379819; ENSP00000369147; ENSG00000137074. [Q7Z2E3-1]
DR   Ensembl; ENST00000379825; ENSP00000369153; ENSG00000137074. [Q7Z2E3-11]
DR   Ensembl; ENST00000397172; ENSP00000380357; ENSG00000137074. [Q7Z2E3-3]
DR   Ensembl; ENST00000436040; ENSP00000400806; ENSG00000137074. [Q7Z2E3-7]
DR   Ensembl; ENST00000460940; ENSP00000418311; ENSG00000137074. [Q7Z2E3-12]
DR   Ensembl; ENST00000463596; ENSP00000419846; ENSG00000137074. [Q7Z2E3-7]
DR   Ensembl; ENST00000467331; ENSP00000418733; ENSG00000137074. [Q7Z2E3-12]
DR   Ensembl; ENST00000468275; ENSP00000420263; ENSG00000137074. [Q7Z2E3-7]
DR   Ensembl; ENST00000472896; ENSP00000417804; ENSG00000137074. [Q7Z2E3-12]
DR   Ensembl; ENST00000476858; ENSP00000419042; ENSG00000137074. [Q7Z2E3-10]
DR   Ensembl; ENST00000479656; ENSP00000420071; ENSG00000137074. [Q7Z2E3-12]
DR   Ensembl; ENST00000482687; ENSP00000419289; ENSG00000137074. [Q7Z2E3-13]
DR   Ensembl; ENST00000485479; ENSP00000418144; ENSG00000137074. [Q7Z2E3-12]
DR   Ensembl; ENST00000494649; ENSP00000417634; ENSG00000137074. [Q7Z2E3-12]
DR   Ensembl; ENST00000495360; ENSP00000419623; ENSG00000137074. [Q7Z2E3-12]
DR   GeneID; 54840; -.
DR   KEGG; hsa:54840; -.
DR   UCSC; uc003zrm.4; human. [Q7Z2E3-1]
DR   CTD; 54840; -.
DR   DisGeNET; 54840; -.
DR   GeneCards; APTX; -.
DR   GeneReviews; APTX; -.
DR   HGNC; HGNC:15984; APTX.
DR   HPA; HPA064930; -.
DR   MalaCards; APTX; -.
DR   MIM; 208920; phenotype.
DR   MIM; 606350; gene.
DR   neXtProt; NX_Q7Z2E3; -.
DR   OpenTargets; ENSG00000137074; -.
DR   Orphanet; 1168; Ataxia - oculomotor apraxia type 1.
DR   PharmGKB; PA24915; -.
DR   eggNOG; KOG0562; Eukaryota.
DR   eggNOG; KOG2134; Eukaryota.
DR   eggNOG; ENOG41102F4; LUCA.
DR   GeneTree; ENSGT00570000079163; -.
DR   HOGENOM; HOG000248858; -.
DR   HOVERGEN; HBG050555; -.
DR   InParanoid; Q7Z2E3; -.
DR   KO; K10863; -.
DR   OMA; PGQVLHM; -.
DR   OrthoDB; EOG091G0KPQ; -.
DR   PhylomeDB; Q7Z2E3; -.
DR   TreeFam; TF313308; -.
DR   SABIO-RK; Q7Z2E3; -.
DR   SIGNOR; Q7Z2E3; -.
DR   ChiTaRS; APTX; human.
DR   EvolutionaryTrace; Q7Z2E3; -.
DR   GeneWiki; Aprataxin; -.
DR   GenomeRNAi; 54840; -.
DR   PRO; PR:Q7Z2E3; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000137074; -.
DR   CleanEx; HS_APTX; -.
DR   ExpressionAtlas; Q7Z2E3; baseline and differential.
DR   Genevisible; Q7Z2E3; HS.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; IDA:UniProtKB.
DR   GO; GO:0033699; F:DNA 5'-adenosine monophosphate hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008967; F:phosphoglycolate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:UniProtKB.
DR   GO; GO:0046403; F:polynucleotide 3'-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0006266; P:DNA ligation; IEA:Ensembl.
DR   GO; GO:0006302; P:double-strand break repair; IDA:UniProtKB.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:UniProtKB.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0000012; P:single strand break repair; IDA:UniProtKB.
DR   Gene3D; 3.30.428.10; -; 1.
DR   InterPro; IPR026963; Aprataxin.
DR   InterPro; IPR000253; FHA_dom.
DR   InterPro; IPR019808; Histidine_triad_CS.
DR   InterPro; IPR011146; HIT-like.
DR   InterPro; IPR008984; SMAD_FHA_domain.
DR   InterPro; IPR032566; Znf-C2HE.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR12486:SF7; PTHR12486:SF7; 1.
DR   Pfam; PF00498; FHA; 1.
DR   Pfam; PF16278; zf-C2HE; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   SUPFAM; SSF54197; SSF54197; 1.
DR   PROSITE; PS00892; HIT_1; 1.
DR   PROSITE; PS51084; HIT_2; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Disease mutation; DNA damage; DNA repair; DNA-binding; Hydrolase;
KW   Metal-binding; Neurodegeneration; Nucleus; Phosphoprotein;
KW   Reference proteome; Zinc; Zinc-finger.
FT   CHAIN         1    356       Aprataxin.
FT                                /FTId=PRO_0000109838.
FT   DOMAIN       38     87       FHA-like.
FT   DOMAIN      182    287       HIT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00464}.
FT   ZN_FING     331    353       C2H2-type.
FT   REGION        1    110       Interactions with ADPRT and NCL.
FT   MOTIF       126    131       Nuclear localization signal.
FT                                {ECO:0000305}.
FT   MOTIF       272    276       Histidine triad motif.
FT   ACT_SITE    274    274       Tele-AMP-histidine intermediate.
FT                                {ECO:0000305}.
FT   MOD_RES     132    132       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     137    137       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q7TQC5}.
FT   VAR_SEQ       1    193       Missing (in isoform 6).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_010534.
FT   VAR_SEQ       1    188       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3, ECO:0000303|Ref.9}.
FT                                /FTId=VSP_010535.
FT   VAR_SEQ       1    102       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3, ECO:0000303|Ref.9}.
FT                                /FTId=VSP_010536.
FT   VAR_SEQ       1     14       Missing (in isoform 5, isoform 7, isoform
FT                                9, isoform 12 and isoform 13).
FT                                {ECO:0000303|PubMed:15276230,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|Ref.3, ECO:0000303|Ref.9}.
FT                                /FTId=VSP_010537.
FT   VAR_SEQ      59    112       Missing (in isoform 5 and isoform 10).
FT                                {ECO:0000303|Ref.3, ECO:0000303|Ref.9}.
FT                                /FTId=VSP_010538.
FT   VAR_SEQ      60     63       QLKA -> ESRV (in isoform 12).
FT                                {ECO:0000303|PubMed:15276230}.
FT                                /FTId=VSP_044091.
FT   VAR_SEQ      64    356       Missing (in isoform 12).
FT                                {ECO:0000303|PubMed:15276230}.
FT                                /FTId=VSP_044092.
FT   VAR_SEQ     104    175       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_010539.
FT   VAR_SEQ     175    193       Missing (in isoform 8).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_010540.
FT   VAR_SEQ     196    356       VYKDEQVVVIKDKYPKARYHWLVLPWTSISSLKAVAREHLE
FT                                LLKHMHTVGEKVIVDFAGSSKLRFRLGYHAIPSMSHVHLHV
FT                                ISQDFDSPCLKNKKHWNSFNTEYFLESQAVIEMVQEAGRVT
FT                                VRDGMPELLKLPLRCHECQQLLPSIPQLKEHLRKHWTQ ->
FT                                PCTSSCDQPGF (in isoform 13).
FT                                {ECO:0000303|PubMed:15276230}.
FT                                /FTId=VSP_044093.
FT   VAR_SEQ     306    356       AVIEMVQEAGRVTVRDGMPELLKLPLRCHECQQLLPSIPQL
FT                                KEHLRKHWTQ -> E (in isoform 6, isoform 9
FT                                and isoform 11).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_010541.
FT   VARIANT     211    211       K -> Q (in AOA).
FT                                {ECO:0000269|PubMed:12629250}.
FT                                /FTId=VAR_018794.
FT   VARIANT     212    212       A -> V (in AOA; heterozygous;
FT                                dbSNP:rs748165574).
FT                                {ECO:0000269|PubMed:14506070}.
FT                                /FTId=VAR_018795.
FT   VARIANT     213    213       R -> H (in AOA; dbSNP:rs150886026).
FT                                {ECO:0000269|PubMed:11586300}.
FT                                /FTId=VAR_018796.
FT   VARIANT     215    215       H -> R (in AOA; dbSNP:rs121908133).
FT                                {ECO:0000269|PubMed:12196655}.
FT                                /FTId=VAR_018797.
FT   VARIANT     220    220       P -> L (in AOA; dbSNP:rs121908131).
FT                                {ECO:0000269|PubMed:11586299,
FT                                ECO:0000269|PubMed:11586300}.
FT                                /FTId=VAR_018798.
FT   VARIANT     237    237       L -> P (in AOA; dbSNP:rs267606665).
FT                                {ECO:0000269|PubMed:15852392}.
FT                                /FTId=VAR_025365.
FT   VARIANT     277    277       V -> G (in AOA; abolishes DNA-binding and
FT                                enzymatic activity towards Ap(4)A;
FT                                dbSNP:rs121908132).
FT                                {ECO:0000269|PubMed:11586299,
FT                                ECO:0000269|PubMed:14506070,
FT                                ECO:0000269|PubMed:16547001}.
FT                                /FTId=VAR_018799.
FT   VARIANT     281    281       D -> G (in AOA; heterozygous).
FT                                /FTId=VAR_018800.
FT   VARIANT     293    293       W -> R (in AOA; heterozygous;
FT                                dbSNP:rs773393618).
FT                                {ECO:0000269|PubMed:14506070}.
FT                                /FTId=VAR_018801.
FT   MUTAGEN      43     43       R->A: Impairs interaction with XRCC1 and
FT                                XRCC4. Abolishes localization at sites of
FT                                DNA double-strand breaks. Loss of
FT                                interaction with MDC1.
FT                                {ECO:0000269|PubMed:15380105,
FT                                ECO:0000269|PubMed:20008512}.
FT   MUTAGEN      52     52       K->A: Impairs interaction with MDC1 and
FT                                localization at sites of DNA double-
FT                                strand breaks.
FT                                {ECO:0000269|PubMed:20008512}.
FT   MUTAGEN     274    274       H->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:16964241,
FT                                ECO:0000269|PubMed:17276982}.
FT   MUTAGEN     333    333       C->A: Abolishes DNA-binding and enzyme
FT                                activity; when associated with A-336.
FT                                {ECO:0000269|PubMed:17276982}.
FT   MUTAGEN     336    336       C->A: Abolishes DNA-binding and enzyme
FT                                activity; when associated with A-333.
FT                                {ECO:0000269|PubMed:17276982}.
FT   STRAND       18     23       {ECO:0000244|PDB:3KT9}.
FT   STRAND       30     32       {ECO:0000244|PDB:3KT9}.
FT   STRAND       38     41       {ECO:0000244|PDB:3KT9}.
FT   TURN         45     47       {ECO:0000244|PDB:3KT9}.
FT   STRAND       59     64       {ECO:0000244|PDB:3KT9}.
FT   TURN         65     68       {ECO:0000244|PDB:3KT9}.
FT   STRAND       69     74       {ECO:0000244|PDB:3KT9}.
FT   STRAND       76     78       {ECO:0000244|PDB:3KT9}.
FT   STRAND       92     95       {ECO:0000244|PDB:3KT9}.
FT   STRAND      101    104       {ECO:0000244|PDB:3KT9}.
FT   STRAND      107    115       {ECO:0000244|PDB:3KT9}.
FT   HELIX       181    183       {ECO:0000244|PDB:4NDH}.
FT   HELIX       184    188       {ECO:0000244|PDB:4NDH}.
FT   TURN        192    194       {ECO:0000244|PDB:4NDH}.
FT   STRAND      195    198       {ECO:0000244|PDB:4NDH}.
FT   STRAND      200    206       {ECO:0000244|PDB:4NDH}.
FT   STRAND      211    222       {ECO:0000244|PDB:4NDH}.
FT   HELIX       227    229       {ECO:0000244|PDB:4NDH}.
FT   HELIX       232    234       {ECO:0000244|PDB:4NDH}.
FT   HELIX       235    253       {ECO:0000244|PDB:4NDH}.
FT   HELIX       254    256       {ECO:0000244|PDB:4NDH}.
FT   STRAND      260    267       {ECO:0000244|PDB:4NDH}.
FT   STRAND      269    272       {ECO:0000244|PDB:4NDH}.
FT   STRAND      275    279       {ECO:0000244|PDB:4NDH}.
FT   HELIX       290    297       {ECO:0000244|PDB:4NDH}.
FT   STRAND      301    303       {ECO:0000244|PDB:4NDH}.
FT   HELIX       304    314       {ECO:0000244|PDB:4NDH}.
FT   HELIX       323    326       {ECO:0000244|PDB:4NDH}.
FT   TURN        334    336       {ECO:0000244|PDB:4NDH}.
FT   STRAND      339    342       {ECO:0000244|PDB:4NDH}.
FT   HELIX       343    350       {ECO:0000244|PDB:4NDH}.
FT   HELIX       351    353       {ECO:0000244|PDB:4NDH}.
SQ   SEQUENCE   356 AA;  40740 MW;  5B338490E35EC8E4 CRC64;
     MSNVNLSVSD FWRVMMRVCW LVRQDSRHQR IRLPHLEAVV IGRGPETKIT DKKCSRQQVQ
     LKAECNKGYV KVKQVGVNPT SIDSVVIGKD QEVKLQPGQV LHMVNELYPY IVEFEEEAKN
     PGLETHRKRK RSGNSDSIER DAAQEAEAGT GLEPGSNSGQ CSVPLKKGKD APIKKESLGH
     WSQGLKISMQ DPKMQVYKDE QVVVIKDKYP KARYHWLVLP WTSISSLKAV AREHLELLKH
     MHTVGEKVIV DFAGSSKLRF RLGYHAIPSM SHVHLHVISQ DFDSPCLKNK KHWNSFNTEY
     FLESQAVIEM VQEAGRVTVR DGMPELLKLP LRCHECQQLL PSIPQLKEHL RKHWTQ
//
ID   ASCC3_HUMAN             Reviewed;        2202 AA.
AC   Q8N3C0; E7EW23; O43738; Q4G1A0; Q5VTN2; Q9H1I9; Q9H5A2; Q9NTR0;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 3.
DT   12-APR-2017, entry version 150.
DE   RecName: Full=Activating signal cointegrator 1 complex subunit 3;
DE            EC=3.6.4.12;
DE   AltName: Full=ASC-1 complex subunit p200;
DE            Short=ASC1p200;
DE   AltName: Full=Helicase, ATP binding 1;
DE   AltName: Full=Trip4 complex subunit p200;
GN   Name=ASCC3; Synonyms=HELIC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   PHE-146.
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 277-2202, PARTIAL PROTEIN SEQUENCE,
RP   VARIANT CYS-1995, IDENTIFICATION OF THE ASC-1 COMPLEX, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12077347; DOI=10.1128/MCB.22.14.5203-5211.2002;
RA   Jung D.-J., Sung H.-S., Goo Y.-W., Lee H.M., Park O.K., Jung S.-Y.,
RA   Lim J., Kim H.-J., Lee S.-K., Kim T.S., Lee J.W., Lee Y.C.;
RT   "Novel transcription coactivator complex containing activating signal
RT   cointegrator 1.";
RL   Mol. Cell. Biol. 22:5203-5211(2002).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1012-2202, AND VARIANT CYS-1995.
RC   TISSUE=Melanoma;
RA   Baurain J.-F.;
RT   "The immunodominant antigen recognized by autologous CTL on a human
RT   melanoma is generated by a point mutation in a new member of the RNA
RT   helicase gene family.";
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-572, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH ALKBH3, AND MUTAGENESIS
RP   OF GLY-1354.
RX   PubMed=22055184; DOI=10.1016/j.molcel.2011.08.039;
RA   Dango S., Mosammaparast N., Sowa M.E., Xiong L.J., Wu F., Park K.,
RA   Rubin M., Gygi S., Harper J.W., Shi Y.;
RT   "DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA
RT   alkylation repair and cancer cell proliferation.";
RL   Mol. Cell 44:373-384(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12 AND SER-2195, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: 3'-5' DNA helicase involved in repair of alkylated DNA.
CC       Promotes DNA unwinding to generate single-stranded substrate
CC       needed for ALKBH3, enabling ALKBH3 to process alkylated N3-
CC       methylcytosine (3mC) within double-stranded regions. Enhances NF-
CC       kappa-B, SRF and AP1 transactivation.
CC       {ECO:0000269|PubMed:22055184}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
CC       {ECO:0000269|PubMed:22055184}.
CC   -!- SUBUNIT: Part of the ASC-1/TRIP4 complex, that contains TRIP4,
CC       ASCC1, ASCC2 and ASCC3. The ASC-1 complex interacts with ALKBH3.
CC       {ECO:0000269|PubMed:12077347, ECO:0000269|PubMed:22055184}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12077347}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8N3C0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N3C0-3; Sequence=VSP_042955, VSP_042956;
CC       Name=3;
CC         IsoId=Q8N3C0-4; Sequence=VSP_042957, VSP_042958;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- SIMILARITY: Belongs to the helicase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG45474.1; Type=Frameshift; Positions=2175; Evidence={ECO:0000305};
CC       Sequence=CAA11679.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAA11679.1; Type=Frameshift; Positions=2175; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL834463; CAD39122.1; -; mRNA.
DR   EMBL; AK315197; BAG37637.1; -; mRNA.
DR   EMBL; AL591585; CAH73862.1; -; Genomic_DNA.
DR   EMBL; AL121965; CAH73862.1; JOINED; Genomic_DNA.
DR   EMBL; AL133338; CAH73862.1; JOINED; Genomic_DNA.
DR   EMBL; AL356122; CAH73862.1; JOINED; Genomic_DNA.
DR   EMBL; Z86062; CAH73862.1; JOINED; Genomic_DNA.
DR   EMBL; AL356122; CAI16190.1; -; Genomic_DNA.
DR   EMBL; AL121965; CAI16190.1; JOINED; Genomic_DNA.
DR   EMBL; AL133338; CAI16190.1; JOINED; Genomic_DNA.
DR   EMBL; AL591585; CAI16190.1; JOINED; Genomic_DNA.
DR   EMBL; Z86062; CAI16190.1; JOINED; Genomic_DNA.
DR   EMBL; Z86062; CAI19454.1; -; Genomic_DNA.
DR   EMBL; AL121965; CAI19454.1; JOINED; Genomic_DNA.
DR   EMBL; AL133338; CAI19454.1; JOINED; Genomic_DNA.
DR   EMBL; AL356122; CAI19454.1; JOINED; Genomic_DNA.
DR   EMBL; AL591585; CAI19454.1; JOINED; Genomic_DNA.
DR   EMBL; AL121965; CAI19627.1; -; Genomic_DNA.
DR   EMBL; AL133338; CAI19627.1; JOINED; Genomic_DNA.
DR   EMBL; AL356122; CAI19627.1; JOINED; Genomic_DNA.
DR   EMBL; AL591585; CAI19627.1; JOINED; Genomic_DNA.
DR   EMBL; Z86062; CAI19627.1; JOINED; Genomic_DNA.
DR   EMBL; AL133338; CAI21439.1; -; Genomic_DNA.
DR   EMBL; AL121965; CAI21439.1; JOINED; Genomic_DNA.
DR   EMBL; AL356122; CAI21439.1; JOINED; Genomic_DNA.
DR   EMBL; AL591585; CAI21439.1; JOINED; Genomic_DNA.
DR   EMBL; Z86062; CAI21439.1; JOINED; Genomic_DNA.
DR   EMBL; AL133338; CAC07337.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48449.1; -; Genomic_DNA.
DR   EMBL; BC050681; AAH50681.1; -; mRNA.
DR   EMBL; BC125211; AAI25212.1; -; mRNA.
DR   EMBL; BC125212; AAI25213.1; -; mRNA.
DR   EMBL; BC026066; AAH26066.1; -; mRNA.
DR   EMBL; AY013288; AAG45474.1; ALT_FRAME; mRNA.
DR   EMBL; AJ223948; CAA11679.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS5046.1; -. [Q8N3C0-1]
DR   CCDS; CCDS5047.1; -. [Q8N3C0-3]
DR   CCDS; CCDS75497.1; -. [Q8N3C0-4]
DR   RefSeq; NP_001271200.1; NM_001284271.1. [Q8N3C0-4]
DR   RefSeq; NP_006819.2; NM_006828.3. [Q8N3C0-1]
DR   RefSeq; NP_071374.1; NM_022091.4. [Q8N3C0-3]
DR   UniGene; Hs.486031; -.
DR   UniGene; Hs.733060; -.
DR   ProteinModelPortal; Q8N3C0; -.
DR   SMR; Q8N3C0; -.
DR   BioGrid; 116170; 32.
DR   IntAct; Q8N3C0; 15.
DR   MINT; MINT-1183138; -.
DR   STRING; 9606.ENSP00000358159; -.
DR   iPTMnet; Q8N3C0; -.
DR   PhosphoSitePlus; Q8N3C0; -.
DR   BioMuta; ASCC3; -.
DR   DMDM; 158518649; -.
DR   EPD; Q8N3C0; -.
DR   MaxQB; Q8N3C0; -.
DR   PaxDb; Q8N3C0; -.
DR   PeptideAtlas; Q8N3C0; -.
DR   PRIDE; Q8N3C0; -.
DR   DNASU; 10973; -.
DR   Ensembl; ENST00000369143; ENSP00000358139; ENSG00000112249. [Q8N3C0-3]
DR   Ensembl; ENST00000369162; ENSP00000358159; ENSG00000112249. [Q8N3C0-1]
DR   Ensembl; ENST00000522650; ENSP00000430769; ENSG00000112249. [Q8N3C0-4]
DR   GeneID; 10973; -.
DR   KEGG; hsa:10973; -.
DR   UCSC; uc003pqk.5; human. [Q8N3C0-1]
DR   CTD; 10973; -.
DR   DisGeNET; 10973; -.
DR   GeneCards; ASCC3; -.
DR   H-InvDB; HIX0021958; -.
DR   HGNC; HGNC:18697; ASCC3.
DR   HPA; HPA031608; -.
DR   HPA; HPA031609; -.
DR   HPA; HPA031610; -.
DR   MIM; 614217; gene.
DR   neXtProt; NX_Q8N3C0; -.
DR   OpenTargets; ENSG00000112249; -.
DR   PharmGKB; PA134890913; -.
DR   eggNOG; KOG0952; Eukaryota.
DR   eggNOG; COG1204; LUCA.
DR   GeneTree; ENSGT00640000091272; -.
DR   HOGENOM; HOG000169284; -.
DR   HOVERGEN; HBG051896; -.
DR   InParanoid; Q8N3C0; -.
DR   KO; K18663; -.
DR   OMA; FLRVNPM; -.
DR   OrthoDB; EOG091G0HE5; -.
DR   PhylomeDB; Q8N3C0; -.
DR   TreeFam; TF105778; -.
DR   Reactome; R-HSA-112126; ALKBH3 mediated reversal of alkylation damage.
DR   ChiTaRS; ASCC3; human.
DR   GeneWiki; ASCC3; -.
DR   GenomeRNAi; 10973; -.
DR   PRO; PR:Q8N3C0; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112249; -.
DR   CleanEx; HS_ASCC3; -.
DR   ExpressionAtlas; Q8N3C0; baseline and differential.
DR   Genevisible; Q8N3C0; HS.
DR   GO; GO:0099053; C:activating signal cointegrator 1 complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005622; C:intracellular; IDA:LIFEdb.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0043140; F:ATP-dependent 3'-5' DNA helicase activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IMP:UniProtKB.
DR   GO; GO:0006307; P:DNA dealkylation involved in DNA repair; IDA:UniProtKB.
DR   GO; GO:0032508; P:DNA duplex unwinding; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.150; -; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR004179; Sec63-dom.
DR   InterPro; IPR011991; WHTH_DNA-bd_dom.
DR   Pfam; PF00270; DEAD; 2.
DR   Pfam; PF00271; Helicase_C; 2.
DR   Pfam; PF02889; Sec63; 2.
DR   SMART; SM00382; AAA; 2.
DR   SMART; SM00487; DEXDc; 2.
DR   SMART; SM00490; HELICc; 2.
DR   SMART; SM00973; Sec63; 2.
DR   SUPFAM; SSF46785; SSF46785; 2.
DR   SUPFAM; SSF52540; SSF52540; 4.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 2.
DR   PROSITE; PS51194; HELICASE_CTER; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Coiled coil;
KW   Complete proteome; Direct protein sequencing; DNA damage; DNA repair;
KW   Helicase; Hydrolase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation.
FT   CHAIN         1   2202       Activating signal cointegrator 1 complex
FT                                subunit 3.
FT                                /FTId=PRO_0000102093.
FT   DOMAIN      486    669       Helicase ATP-binding 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN      728    914       Helicase C-terminal 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00542}.
FT   DOMAIN      978   1287       SEC63 1.
FT   DOMAIN     1336   1511       Helicase ATP-binding 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00541}.
FT   DOMAIN     1544   1739       Helicase C-terminal 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00542}.
FT   DOMAIN     1812   2176       SEC63 2.
FT   NP_BIND     499    506       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00541}.
FT   NP_BIND    1349   1356       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00541}.
FT   COILED       18     79       {ECO:0000255}.
FT   COILED      328    356       {ECO:0000255}.
FT   MOTIF       611    614       DEVH box.
FT   MOTIF      1453   1456       DEIH box.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     572    572       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    2195   2195       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      81    111       VGTDNGREAIESGAAFLFMTFHLKDSVGHKE -> EVNCPF
FT                                QKRRLDGKEEDEKMSRASDRFRGLR (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042955.
FT   VAR_SEQ     112   2202       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042956.
FT   VAR_SEQ     719    731       MVFVHARNATVRT -> HLFYLLLHLFICF (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042957.
FT   VAR_SEQ     732   2202       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042958.
FT   VARIANT     146    146       L -> F (in dbSNP:rs9390698).
FT                                {ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_034859.
FT   VARIANT     344    344       E -> K (in dbSNP:rs6918004).
FT                                /FTId=VAR_049339.
FT   VARIANT     478    478       N -> S (in dbSNP:rs7750940).
FT                                /FTId=VAR_049340.
FT   VARIANT    1016   1016       S -> C (in dbSNP:rs57534235).
FT                                /FTId=VAR_061212.
FT   VARIANT    1050   1050       V -> I (in dbSNP:rs9497983).
FT                                /FTId=VAR_034860.
FT   VARIANT    1425   1425       V -> A (in dbSNP:rs17246013).
FT                                /FTId=VAR_049341.
FT   VARIANT    1497   1497       R -> T (in dbSNP:rs17305382).
FT                                /FTId=VAR_049342.
FT   VARIANT    1800   1800       C -> W (in dbSNP:rs35011147).
FT                                /FTId=VAR_034861.
FT   VARIANT    1930   1930       V -> M (in dbSNP:rs3213542).
FT                                /FTId=VAR_034862.
FT   VARIANT    1995   1995       S -> C (in dbSNP:rs240780).
FT                                {ECO:0000269|PubMed:12077347,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_034863.
FT   VARIANT    2176   2176       Y -> C (in dbSNP:rs240768).
FT                                /FTId=VAR_034864.
FT   MUTAGEN    1354   1354       G->D: Abolishes 3'-5' DNA helicase
FT                                activity and ability to promote DNA
FT                                repair. {ECO:0000269|PubMed:22055184}.
FT   CONFLICT     86     86       G -> E (in Ref. 5; AAH26066).
FT                                {ECO:0000305}.
FT   CONFLICT    269    277       Missing (in Ref. 2; CAH73862/CAI16190/
FT                                CAI19454/CAI19627/CAI21439).
FT                                {ECO:0000305}.
FT   CONFLICT    444    444       P -> S (in Ref. 1; CAD39122).
FT                                {ECO:0000305}.
FT   CONFLICT    582    582       V -> A (in Ref. 5; AAH26066).
FT                                {ECO:0000305}.
FT   CONFLICT    750    750       P -> S (in Ref. 1; CAD39122).
FT                                {ECO:0000305}.
FT   CONFLICT   1187   1187       S -> F (in Ref. 7; CAA11679).
FT                                {ECO:0000305}.
FT   CONFLICT   1343   1343       C -> S (in Ref. 7; CAA11679).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2202 AA;  251460 MW;  9F074E6E5853399C CRC64;
     MALPRLTGAL RSFSNVTKQD NYNEEVADLK IKRSKLHEQV LDLGLTWKKI IKFLNEKLEK
     SKMQSINEDL KDILHAAKQI VGTDNGREAI ESGAAFLFMT FHLKDSVGHK ETKAIKQMFG
     PFPSSSATAA CNATNRIISH FSQDDLTALV QMTEKEHGDR VFFGKNLAFS FDMHDLDHFD
     ELPINGETQK TISLDYKKFL NEHLQEACTP ELKPVEKTNG SFLWCEVEKY LNSTLKEMTE
     VPRVEDLCCT LYDMLASIKS GDELQDELFE LLGPEGLELI EKLLQNRITI VDRFLNSSND
     HRFQALQDNC KKILGENAKP NYGCQVTIQS EQEKQLMKQY RREEKRIARR EKKAGEDLEV
     SEGLMCFDPK ELRIQREQAL LNARSVPILS RQRDADVEKI HYPHVYDSQA EAMKTSAFIA
     GAKMILPEGI QRENNKLYEE VRIPYSEPMP LSFEEKPVYI QDLDEIGQLA FKGMKRLNRI
     QSIVFETAYN TNENMLICAP TGAGKTNIAM LTVLHEIRQH FQQGVIKKNE FKIVYVAPMK
     ALAAEMTDYF SRRLEPLGII VKELTGDMQL SKSEILRTQM LVTTPEKWDV VTRKSVGDVA
     LSQIVRLLIL DEVHLLHEDR GPVLESIVAR TLRQVESTQS MIRILGLSAT LPNYLDVATF
     LHVNPYIGLF FFDGRFRPVP LGQTFLGIKC ANKMQQLNNM DEVCYENVLK QVKAGHQVMV
     FVHARNATVR TAMSLIERAK NCGHIPFFFP TQGHDYVLAE KQVQRSRNKQ VRELFPDGFS
     IHHAGMLRQD RNLVENLFSN GHIKVLVCTA TLAWGVNLPA HAVIIKGTQI YAAKRGSFVD
     LGILDVMQIF GRAGRPQFDK FGEGIIITTH DKLSHYLTLL TQRNPIESQF LESLADNLNA
     EIALGTVTNV EEAVKWISYT YLYVRMRANP LAYGISHKAY QIDPTLRKHR EQLVIEVGRK
     LDKAQMIRFE ERTGYFSSTD LGRTASHYYI KYNTIETFNE LFDAHKTEGD IFAIVSKAEE
     FDQIKVREEE IEELDTLLSN FCELSTPGGV ENSYGKINIL LQTYISRGEM DSFSLISDSA
     YVAQNAARIV RALFEIALRK RWPTMTYRLL NLSKVIDKRL WGWASPLRQF SILPPHILTR
     LEEKKLTVDK LKDMRKDEIG HILHHVNIGL KVKQCVHQIP SVMMEASIQP ITRTVLRVTL
     SIYADFTWND QVHGTVGEPW WIWVEDPTND HIYHSEYFLA LKKQVISKEA QLLVFTIPIF
     EPLPSQYYIR AVSDRWLGAE AVCIINFQHL ILPERHPPHT ELLDLQPLPI TALGCKAYEA
     LYNFSHFNPV QTQIFHTLYH TDCNVLLGAP TGSGKTVAAE LAIFRVFNKY PTSKAVYIAP
     LKALVRERMD DWKVRIEEKL GKKVIELTGD VTPDMKSIAK ADLIVTTPEK WDGVSRSWQN
     RNYVQQVTIL IIDEIHLLGE ERGPVLEVIV SRTNFISSHT EKPVRIVGLS TALANARDLA
     DWLNIKQMGL FNFRPSVRPV PLEVHIQGFP GQHYCPRMAS MNKPAFQAIR SHSPAKPVLI
     FVSSRRQTRL TALELIAFLA TEEDPKQWLN MDEREMENII ATVRDSNLKL TLAFGIGMHH
     AGLHERDRKT VEELFVNCKV QVLIATSTLA WGVNFPAHLV IIKGTEYYDG KTRRYVDFPI
     TDVLQMMGRA GRPQFDDQGK AVILVHDIKK DFYKKFLYEP FPVESSLLGV LSDHLNAEIA
     GGTITSKQDA LDYITWTYFF RRLIMNPSYY NLGDVSHDSV NKFLSHLIEK SLIELELSYC
     IEIGEDNRSI EPLTYGRIAS YYYLKHQTVK MFKDRLKPEC STEELLSILS DAEEYTDLPV
     RHNEDHMNSE LAKCLPIESN PHSFDSPHTK AHLLLQAHLS RAMLPCPDYD TDTKTVLDQA
     LRVCQAMLDV AANQGWLVTV LNITNLIQMV IQGRWLKDSS LLTLPNIENH HLHLFKKWKP
     IMKGPHARGR TSIESLPELI HACGGKDHVF SSMVESELHA AKTKQAWNFL SHLPVINVGI
     SVKGSWDDLV EGHNELSVST LTADKRDDNK WIKLHADQEY VLQVSLQRVH FGFHKGKPES
     CAVTPRFPKS KDEGWFLILG EVDKRELIAL KRVGYIRNHH VASLSFYTPE IPGRYIYTLY
     FMSDCYLGLD QQYDIYLNVT QASLSAQVNT KVSDSLTDLA LK
//
ID   TDT_HUMAN               Reviewed;         509 AA.
AC   P04053; Q53FH1; Q5W103; Q96E50;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   06-JUL-2016, entry version 178.
DE   RecName: Full=DNA nucleotidylexotransferase;
DE            EC=2.7.7.31 {ECO:0000269|PubMed:11473582, ECO:0000269|PubMed:16371131, ECO:0000269|PubMed:8163485};
DE   AltName: Full=Terminal addition enzyme;
DE   AltName: Full=Terminal deoxynucleotidyltransferase;
DE            Short=Terminal transferase {ECO:0000303|PubMed:11473582};
GN   Name=DNTT; Synonyms=TDT {ECO:0000303|PubMed:11473582};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT GLY-112.
RX   PubMed=2863268;
RA   Peterson R.C., Cheung L.C., Mattaliano R.J., White S.T., Chang L.M.S.,
RA   Bollum F.J.;
RT   "Expression of human terminal deoxynucleotidyl transferase in
RT   Escherichia coli.";
RL   J. Biol. Chem. 260:10495-10502(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLY-112.
RX   PubMed=2833741; DOI=10.1073/pnas.85.8.2489;
RA   Riley L.K., Morrow J.K., Danton M.J., Coleman M.S.;
RT   "Human terminal deoxyribonucleotidyltransferase: molecular cloning and
RT   structural analysis of the gene and 5' flanking region.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:2489-2493(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLY-112.
RX   PubMed=11554927; DOI=10.1046/j.1365-2443.2001.00460.x;
RA   Ibe S., Fujita K., Toyomoto T., Shimazaki N., Kaneko R., Tanabe A.,
RA   Takebe I., Kuroda S., Kobayashi T., Toji S., Tamai K., Yamamoto H.,
RA   Koiwai O.;
RT   "Terminal deoxynucleotidyltransferase is negatively regulated by
RT   direct interaction with proliferating cell nuclear antigen.";
RL   Genes Cells 6:815-824(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLY-112.
RC   TISSUE=Thymus;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLY-112.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-67.
RX   PubMed=3395350; DOI=10.1016/0006-291X(88)90654-7;
RA   Koiwai O., Morita A.;
RT   "Isolation of putative promoter region for human terminal
RT   deoxynucleotidyltransferase gene.";
RL   Biochem. Biophys. Res. Commun. 154:91-100(1988).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 271-508 (ISOFORM 2).
RX   PubMed=6087320; DOI=10.1073/pnas.81.14.4363;
RA   Peterson R.C., Cheung L.C., Mattaliano R.J., Chang L.M.S.,
RA   Bollum F.J.;
RT   "Molecular cloning of human terminal deoxynucleotidyltransferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:4363-4367(1984).
RN   [9]
RP   MUTAGENESIS OF ASP-343, AND CATALYTIC ACTIVITY.
RX   PubMed=8163485;
RA   Yang B., Gathy K.N., Coleman M.S.;
RT   "Mutational analysis of residues in the nucleotide binding domain of
RT   human terminal deoxynucleotidyl transferase.";
RL   J. Biol. Chem. 269:11859-11868(1994).
RN   [10]
RP   INTERACTION WITH DNTTIP1, CATALYTIC ACTIVITY, AND COFACTOR.
RC   TISSUE=Thymus;
RX   PubMed=11473582; DOI=10.1046/j.1365-2443.2001.00449.x;
RA   Yamashita N., Shimazaki N., Ibe S., Kaneko R., Tanabe A., Toyomoto T.,
RA   Fujita K., Hasegawa T., Toji S., Tamai K., Yamamoto H., Koiwai O.;
RT   "Terminal deoxynucleotidyltransferase directly interacts with a novel
RT   nuclear protein that is homologous to p65.";
RL   Genes Cells 6:641-652(2001).
RN   [11]
RP   INTERACTION WITH DNTTIP2 AND CORE HISTONE.
RX   PubMed=12786946; DOI=10.1046/j.1365-2443.2003.00656.x;
RA   Fujita K., Shimazaki N., Ohta Y., Kubota T., Ibe S., Toji S.,
RA   Tamai K., Fujisaki S., Hayano T., Koiwai O.;
RT   "Terminal deoxynucleotidyltransferase forms a ternary complex with a
RT   novel chromatin remodeling protein with 82 kDa and core histone.";
RL   Genes Cells 8:559-571(2003).
RN   [12]
RP   INTERACTION WITH PRP19.
RX   PubMed=12960389; DOI=10.1073/pnas.1631060100;
RA   Mahajan K.N., Mitchell B.S.;
RT   "Role of human Pso4 in mammalian DNA repair and association with
RT   terminal deoxynucleotidyl transferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:10746-10751(2003).
RN   [13]
RP   INTERACTION WITH DNTTIP1 AND TRERF1, SUBCELLULAR LOCATION, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=16371131; DOI=10.1111/j.1365-2443.2005.00916.x;
RA   Fujisaki S., Sato A., Toyomoto T., Hayano T., Sugai M., Kubota T.,
RA   Koiwai O.;
RT   "Direct binding of TReP-132 with TdT results in reduction of TdT
RT   activity.";
RL   Genes Cells 11:47-57(2006).
RN   [14]
RP   STRUCTURE BY NMR OF 19-125.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of BRCT domain of terminal
RT   deoxynucleotidyltransferase.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Template-independent DNA polymerase which catalyzes the
CC       random addition of deoxynucleoside 5'-triphosphate to the 3'-end
CC       of a DNA initiator. One of the in vivo functions of this enzyme is
CC       the addition of nucleotides at the junction (N region) of
CC       rearranged Ig heavy chain and T-cell receptor gene segments during
CC       the maturation of B- and T-cells. {ECO:0000250|UniProtKB:P09838}.
CC   -!- CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) =
CC       diphosphate + DNA(n+1). {ECO:0000269|PubMed:11473582,
CC       ECO:0000269|PubMed:16371131, ECO:0000269|PubMed:8163485}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000305|PubMed:11473582};
CC       Note=Can also utilize other divalent cations, such as Mn(2+) and
CC       Co(2+) (in vitro). {ECO:0000250|UniProtKB:P09838, ECO:0000305};
CC   -!- SUBUNIT: Interacts with PRP19 and DNTTIP1. Forms a ternary complex
CC       with DNTTIP2 and core histone. Released from this complex by PCNA.
CC       Interacts with TRERF1 (PubMed:16371131).
CC       {ECO:0000269|PubMed:11473582, ECO:0000269|PubMed:12786946,
CC       ECO:0000269|PubMed:12960389, ECO:0000269|PubMed:16371131}.
CC   -!- INTERACTION:
CC       Q04864:REL; NbExp=3; IntAct=EBI-1220259, EBI-307352;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16371131}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P04053-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P04053-2; Sequence=VSP_038397;
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-X family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 BRCT domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00033}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M11722; AAA36726.1; -; mRNA.
DR   EMBL; M20703; AAA53100.1; -; mRNA.
DR   EMBL; M22968; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20694; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20695; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20696; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20697; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20698; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20699; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20700; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20701; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20702; AAA53100.1; JOINED; mRNA.
DR   EMBL; AB046378; BAB72001.1; -; mRNA.
DR   EMBL; AK223317; BAD97037.1; -; mRNA.
DR   EMBL; AL136181; CAH72984.1; -; Genomic_DNA.
DR   EMBL; BC012920; AAH12920.1; -; mRNA.
DR   EMBL; M21195; AAA61137.1; -; Genomic_DNA.
DR   EMBL; K01919; AAA61136.1; -; mRNA.
DR   CCDS; CCDS44465.1; -. [P04053-2]
DR   CCDS; CCDS7447.1; -. [P04053-1]
DR   PIR; A23924; WXHU.
DR   RefSeq; NP_001017520.1; NM_001017520.1. [P04053-2]
DR   RefSeq; NP_004079.3; NM_004088.3. [P04053-1]
DR   UniGene; Hs.534206; -.
DR   PDB; 2COE; NMR; -; A=19-125.
DR   PDBsum; 2COE; -.
DR   ProteinModelPortal; P04053; -.
DR   SMR; P04053; 21-125, 149-509.
DR   BioGrid; 108127; 9.
DR   IntAct; P04053; 2.
DR   STRING; 9606.ENSP00000360216; -.
DR   BindingDB; P04053; -.
DR   ChEMBL; CHEMBL4810; -.
DR   iPTMnet; P04053; -.
DR   PhosphoSite; P04053; -.
DR   BioMuta; DNTT; -.
DR   DMDM; 311033533; -.
DR   MaxQB; P04053; -.
DR   PaxDb; P04053; -.
DR   PeptideAtlas; P04053; -.
DR   PRIDE; P04053; -.
DR   DNASU; 1791; -.
DR   Ensembl; ENST00000371174; ENSP00000360216; ENSG00000107447. [P04053-1]
DR   Ensembl; ENST00000630152; ENSP00000486733; ENSG00000107447. [P04053-2]
DR   GeneID; 1791; -.
DR   KEGG; hsa:1791; -.
DR   UCSC; uc001kmf.4; human. [P04053-1]
DR   CTD; 1791; -.
DR   GeneCards; DNTT; -.
DR   H-InvDB; HIX0009072; -.
DR   HGNC; HGNC:2983; DNTT.
DR   HPA; HPA044194; -.
DR   MIM; 187410; gene.
DR   neXtProt; NX_P04053; -.
DR   PharmGKB; PA27449; -.
DR   eggNOG; KOG2534; Eukaryota.
DR   eggNOG; COG1796; LUCA.
DR   GeneTree; ENSGT00530000063002; -.
DR   HOGENOM; HOG000263600; -.
DR   HOVERGEN; HBG003670; -.
DR   InParanoid; P04053; -.
DR   KO; K00977; -.
DR   OMA; KTWKAIR; -.
DR   OrthoDB; EOG7BS4BH; -.
DR   PhylomeDB; P04053; -.
DR   TreeFam; TF103012; -.
DR   SABIO-RK; P04053; -.
DR   SignaLink; P04053; -.
DR   EvolutionaryTrace; P04053; -.
DR   GeneWiki; Terminal_deoxynucleotidyl_transferase; -.
DR   GenomeRNAi; 1791; -.
DR   PRO; PR:P04053; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; P04053; -.
DR   CleanEx; HS_DNTT; -.
DR   Genevisible; P04053; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003912; F:DNA nucleotidylexotransferase activity; IDA:UniProtKB.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006259; P:DNA metabolic process; IDA:UniProtKB.
DR   GO; GO:0006304; P:DNA modification; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.150.110; -; 1.
DR   Gene3D; 3.30.210.10; -; 1.
DR   Gene3D; 3.40.50.10190; -; 1.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR002054; DNA-dir_DNA_pol_X.
DR   InterPro; IPR019843; DNA_pol-X_BS.
DR   InterPro; IPR010996; DNA_pol_b-like_N.
DR   InterPro; IPR028207; DNA_pol_B_palm_palm.
DR   InterPro; IPR018944; DNA_pol_lambd_fingers_domain.
DR   InterPro; IPR022312; DNA_pol_X.
DR   InterPro; IPR027421; DNA_pol_X_lyase_dom.
DR   InterPro; IPR029398; PolB_thumb.
DR   InterPro; IPR027292; TdT.
DR   InterPro; IPR001726; TdT/Mu.
DR   Pfam; PF00533; BRCT; 1.
DR   Pfam; PF14792; DNA_pol_B_palm; 1.
DR   Pfam; PF14791; DNA_pol_B_thumb; 1.
DR   Pfam; PF10391; DNA_pol_lambd_f; 1.
DR   Pfam; PF14716; HHH_8; 1.
DR   PIRSF; PIRSF000817; DNA_NT; 1.
DR   PIRSF; PIRSF501175; TDT; 1.
DR   PRINTS; PR00869; DNAPOLX.
DR   PRINTS; PR00871; DNAPOLXTDT.
DR   SMART; SM00292; BRCT; 1.
DR   SMART; SM00483; POLXc; 1.
DR   SUPFAM; SSF47802; SSF47802; 1.
DR   SUPFAM; SSF52113; SSF52113; 1.
DR   PROSITE; PS50172; BRCT; 1.
DR   PROSITE; PS00522; DNA_POLYMERASE_X; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Magnesium;
KW   Metal-binding; Nucleotidyltransferase; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Terminal addition; Transferase.
FT   CHAIN         1    509       DNA nucleotidylexotransferase.
FT                                /FTId=PRO_0000218791.
FT   DOMAIN       27    124       BRCT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   REGION      151    509       Mediates interaction with DNTTIP2.
FT                                {ECO:0000269|PubMed:12786946}.
FT   REGION      258    262       Involved in DNA binding.
FT                                {ECO:0000250|UniProtKB:P09838}.
FT   REGION      333    338       Deoxynucleoside triphosphate binding.
FT                                {ECO:0000250|UniProtKB:P09838}.
FT   REGION      342    345       Deoxynucleoside triphosphate binding.
FT                                {ECO:0000250|UniProtKB:P09838}.
FT   REGION      448    449       Deoxynucleoside triphosphate binding.
FT                                {ECO:0000250|UniProtKB:P09838}.
FT   METAL       343    343       Magnesium.
FT                                {ECO:0000250|UniProtKB:P09838}.
FT   METAL       345    345       Magnesium.
FT                                {ECO:0000250|UniProtKB:P09838}.
FT   METAL       433    433       Magnesium.
FT                                {ECO:0000250|UniProtKB:P09838}.
FT   MOD_RES     134    134       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P09838}.
FT   VAR_SEQ     454    454       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:2863268,
FT                                ECO:0000303|PubMed:6087320}.
FT                                /FTId=VSP_038397.
FT   VARIANT     112    112       R -> G (in dbSNP:rs6584066).
FT                                {ECO:0000269|PubMed:11554927,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2833741,
FT                                ECO:0000269|PubMed:2863268,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_058200.
FT   MUTAGEN     343    343       D->E: Nearly abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:8163485}.
FT   CONFLICT     51     51       F -> L (in Ref. 4; BAD97037).
FT                                {ECO:0000305}.
FT   CONFLICT    299    299       L -> P (in Ref. 4; BAD97037).
FT                                {ECO:0000305}.
FT   CONFLICT    329    329       T -> A (in Ref. 4; BAD97037).
FT                                {ECO:0000305}.
FT   CONFLICT    383    383       T -> A (in Ref. 4; BAD97037).
FT                                {ECO:0000305}.
FT   CONFLICT    389    389       L -> M (in Ref. 4; BAD97037).
FT                                {ECO:0000305}.
FT   CONFLICT    452    452       S -> SP (in Ref. 2; AAA53100).
FT                                {ECO:0000305}.
FT   STRAND       23     25       {ECO:0000244|PDB:2COE}.
FT   STRAND       36     40       {ECO:0000244|PDB:2COE}.
FT   TURN         42     44       {ECO:0000244|PDB:2COE}.
FT   HELIX        46     58       {ECO:0000244|PDB:2COE}.
FT   STRAND       73     78       {ECO:0000244|PDB:2COE}.
FT   HELIX        81     90       {ECO:0000244|PDB:2COE}.
FT   STRAND      100    103       {ECO:0000244|PDB:2COE}.
FT   HELIX       104    112       {ECO:0000244|PDB:2COE}.
FT   STRAND      120    124       {ECO:0000244|PDB:2COE}.
SQ   SEQUENCE   509 AA;  58536 MW;  0EC01E380FA7E5A2 CRC64;
     MDPPRASHLS PRKKRPRQTG ALMASSPQDI KFQDLVVFIL EKKMGTTRRA FLMELARRKG
     FRVENELSDS VTHIVAENNS GSDVLEWLQA QKVQVSSQPE LLDVSWLIEC IRAGKPVEMT
     GKHQLVVRRD YSDSTNPGPP KTPPIAVQKI SQYACQRRTT LNNCNQIFTD AFDILAENCE
     FRENEDSCVT FMRAASVLKS LPFTIISMKD TEGIPCLGSK VKGIIEEIIE DGESSEVKAV
     LNDERYQSFK LFTSVFGVGL KTSEKWFRMG FRTLSKVRSD KSLKFTRMQK AGFLYYEDLV
     SCVTRAEAEA VSVLVKEAVW AFLPDAFVTM TGGFRRGKKM GHDVDFLITS PGSTEDEEQL
     LQKVMNLWEK KGLLLYYDLV ESTFEKLRLP SRKVDALDHF QKCFLIFKLP RQRVDSDQSS
     WQEGKTWKAI RVDLVLCPYE RRAFALLGWT GSRQFERDLR RYATHERKMI LDNHALYDKT
     KRIFLKAESE EEIFAHLGLD YIEPWERNA
//
ID   DNLI1_HUMAN             Reviewed;         919 AA.
AC   P18858; B2RAI8; B4DTU4; Q2TB12; Q32P23;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   06-JUL-2016, entry version 182.
DE   RecName: Full=DNA ligase 1;
DE            EC=6.5.1.1;
DE   AltName: Full=DNA ligase I;
DE   AltName: Full=Polydeoxyribonucleotide synthase [ATP] 1;
GN   Name=LIG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=T lymphoblast;
RX   PubMed=2204063; DOI=10.1073/pnas.87.17.6679;
RA   Barnes D.E., Johnston L.H., Kodama K., Tomkinson A.E., Lasko D.D.,
RA   Lindahl T.;
RT   "Human DNA ligase I cDNA: cloning and functional expression in
RT   Saccharomyces cerevisiae.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:6679-6683(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-24; TRP-62;
RP   GLU-249; SER-267; MET-349; ILE-369; VAL-480; ILE-614 AND LEU-677.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Placenta, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 716-753 (ISOFORM 1).
RX   PubMed=1881902; DOI=10.1073/pnas.88.17.7615;
RA   Petrini J.H.J., Huwiler K.G., Weaver D.T.;
RT   "A wild-type DNA ligase I gene is expressed in Bloom's syndrome
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:7615-7619(1991).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66; SER-76 AND SER-141,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51; SER-66; SER-76;
RP   THR-195 AND THR-233, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66 AND SER-76, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.M700120-MCP200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,
RA   Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate
RT   reductase M2 subunit phosphorylation at residue serine 20 in canonical
RT   Wnt signal transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51; SER-141; THR-195;
RP   SER-201; THR-233; SER-911 AND SER-913, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-422.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18655026; DOI=10.1002/pmic.200700887;
RA   Tan F., Lu L., Cai Y., Wang J., Xie Y., Wang L., Gong Y., Xu B.-E.,
RA   Wu J., Luo Y., Qiang B., Yuan J., Sun X., Peng X.;
RT   "Proteomic analysis of ubiquitinated proteins in normal hepatocyte
RT   cell line Chang liver cells.";
RL   Proteomics 8:2885-2896(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49; SER-51; SER-66;
RP   SER-141; THR-195; SER-201; SER-911 AND SER-913, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-49; SER-51;
RP   SER-66; SER-76; SER-141; THR-195; SER-201 AND SER-911, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51; SER-66; SER-76;
RP   SER-141 AND THR-195, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-51; SER-66;
RP   SER-76; SER-141; THR-195; SER-199; SER-201; THR-207; SER-229; SER-230;
RP   THR-798; SER-801 AND SER-819, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   INTERACTION WITH PCNA.
RX   PubMed=24911150; DOI=10.1172/JCI74593;
RA   Baple E.L., Chambers H., Cross H.E., Fawcett H., Nakazawa Y.,
RA   Chioza B.A., Harlalka G.V., Mansour S., Sreekantan-Nair A.,
RA   Patton M.A., Muggenthaler M., Rich P., Wagner K., Coblentz R.,
RA   Stein C.K., Last J.I., Taylor A.M., Jackson A.P., Ogi T.,
RA   Lehmann A.R., Green C.M., Crosby A.H.;
RT   "Hypomorphic PCNA mutation underlies a human DNA repair disorder.";
RL   J. Clin. Invest. 124:3137-3146(2014).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 233-919 IN COMPLEX WITH
RP   NICKED DNA AND AMP, COFACTOR, AND ACTIVE SITE.
RX   PubMed=15565146; DOI=10.1038/nature03082;
RA   Pascal J.M., O'Brien P.J., Tomkinson A.E., Ellenberger T.;
RT   "Human DNA ligase I completely encircles and partially unwinds nicked
RT   DNA.";
RL   Nature 432:473-478(2004).
RN   [21]
RP   VARIANTS LYS-566 AND TRP-771.
RX   PubMed=1581963; DOI=10.1016/0092-8674(92)90450-Q;
RA   Barnes D.E., Tomkinson A.E., Lehmann A.R., Webster A.D.B., Lindahl T.;
RT   "Mutations in the DNA ligase I gene of an individual with
RT   immunodeficiencies and cellular hypersensitivity to DNA-damaging
RT   agents.";
RL   Cell 69:495-503(1992).
RN   [22]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-152 AND LEU-612.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: DNA ligase that seals nicks in double-stranded DNA
CC       during DNA replication, DNA recombination and DNA repair.
CC   -!- CATALYTIC ACTIVITY: ATP + (deoxyribonucleotide)(n) +
CC       (deoxyribonucleotide)(m) = AMP + diphosphate +
CC       (deoxyribonucleotide)(n+m). {ECO:0000255|PROSITE-
CC       ProRule:PRU10135}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:15565146};
CC   -!- SUBUNIT: Interacts with PCNA. {ECO:0000269|PubMed:24911150}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P18858-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P18858-2; Sequence=VSP_056139, VSP_056140;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P18858-3; Sequence=VSP_057320, VSP_057321;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the ATP-dependent DNA ligase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=LIG1base; Note=LIG1 mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/LIG1base/";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/lig1/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=DNA ligase entry;
CC       URL="https://en.wikipedia.org/wiki/DNA_ligase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M36067; AAA59518.1; -; mRNA.
DR   EMBL; AF527418; AAM77697.1; -; Genomic_DNA.
DR   EMBL; AK300370; BAG62106.1; -; mRNA.
DR   EMBL; AK314210; BAG36885.1; -; mRNA.
DR   EMBL; AC011466; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877741; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471177; EAW52316.1; -; Genomic_DNA.
DR   EMBL; BC108318; AAI08319.1; -; mRNA.
DR   EMBL; BC110622; AAI10623.1; -; mRNA.
DR   CCDS; CCDS12711.1; -. [P18858-1]
DR   CCDS; CCDS74409.1; -. [P18858-3]
DR   PIR; A36048; A41275.
DR   RefSeq; NP_000225.1; NM_000234.2. [P18858-1]
DR   RefSeq; NP_001275992.1; NM_001289063.1. [P18858-3]
DR   RefSeq; NP_001275993.1; NM_001289064.1.
DR   RefSeq; NP_001307899.1; NM_001320970.1.
DR   RefSeq; NP_001307900.1; NM_001320971.1.
DR   RefSeq; XP_006723279.1; XM_006723216.2. [P18858-1]
DR   UniGene; Hs.1770; -.
DR   PDB; 1X9N; X-ray; 3.00 A; A=233-919.
DR   PDBsum; 1X9N; -.
DR   ProteinModelPortal; P18858; -.
DR   SMR; P18858; 262-901.
DR   BioGrid; 110166; 16.
DR   DIP; DIP-24215N; -.
DR   IntAct; P18858; 7.
DR   MINT; MINT-141868; -.
DR   STRING; 9606.ENSP00000263274; -.
DR   BindingDB; P18858; -.
DR   ChEMBL; CHEMBL5694; -.
DR   DrugBank; DB00290; Bleomycin.
DR   iPTMnet; P18858; -.
DR   PhosphoSite; P18858; -.
DR   BioMuta; LIG1; -.
DR   DMDM; 118773; -.
DR   EPD; P18858; -.
DR   MaxQB; P18858; -.
DR   PaxDb; P18858; -.
DR   PeptideAtlas; P18858; -.
DR   PRIDE; P18858; -.
DR   Ensembl; ENST00000263274; ENSP00000263274; ENSG00000105486. [P18858-1]
DR   Ensembl; ENST00000427526; ENSP00000442841; ENSG00000105486. [P18858-3]
DR   Ensembl; ENST00000601091; ENSP00000471836; ENSG00000105486. [P18858-2]
DR   Ensembl; ENST00000613670; ENSP00000483027; ENSG00000105486. [P18858-2]
DR   GeneID; 3978; -.
DR   KEGG; hsa:3978; -.
DR   UCSC; uc002pia.2; human. [P18858-1]
DR   CTD; 3978; -.
DR   GeneCards; LIG1; -.
DR   HGNC; HGNC:6598; LIG1.
DR   HPA; CAB037015; -.
DR   HPA; HPA041431; -.
DR   HPA; HPA048071; -.
DR   MIM; 126391; gene.
DR   neXtProt; NX_P18858; -.
DR   PharmGKB; PA30372; -.
DR   eggNOG; KOG0967; Eukaryota.
DR   eggNOG; COG1793; LUCA.
DR   GeneTree; ENSGT00840000129855; -.
DR   HOGENOM; HOG000036006; -.
DR   HOVERGEN; HBG005514; -.
DR   InParanoid; P18858; -.
DR   KO; K10747; -.
DR   OMA; PQVVIEV; -.
DR   OrthoDB; EOG7RFTGN; -.
DR   PhylomeDB; P18858; -.
DR   TreeFam; TF300342; -.
DR   BRENDA; 6.5.1.1; 2681.
DR   Reactome; R-HSA-110362; POLB-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-174414; Processive synthesis on the C-strand of the telomere.
DR   Reactome; R-HSA-5358565; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha).
DR   Reactome; R-HSA-5358606; Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta).
DR   Reactome; R-HSA-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-69183; Processive synthesis on the lagging strand.
DR   SIGNOR; P18858; -.
DR   ChiTaRS; LIG1; human.
DR   EvolutionaryTrace; P18858; -.
DR   GeneWiki; LIG1; -.
DR   GenomeRNAi; 3978; -.
DR   PRO; PR:P18858; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; P18858; -.
DR   CleanEx; HS_LIG1; -.
DR   ExpressionAtlas; P18858; baseline and differential.
DR   Genevisible; P18858; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0003910; F:DNA ligase (ATP) activity; IBA:GO_Central.
DR   GO; GO:0003909; F:DNA ligase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0006284; P:base-excision repair; IDA:BHF-UCL.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071897; P:DNA biosynthetic process; IEA:InterPro.
DR   GO; GO:0006259; P:DNA metabolic process; TAS:ProtInc.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0006298; P:mismatch repair; TAS:Reactome.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome.
DR   GO; GO:1903461; P:Okazaki fragment processing involved in mitotic DNA replication; IBA:GO_Central.
DR   GO; GO:0000722; P:telomere maintenance via recombination; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   Gene3D; 1.10.3260.10; -; 1.
DR   Gene3D; 2.40.50.140; -; 1.
DR   InterPro; IPR000977; DNA_ligase_ATP-dep.
DR   InterPro; IPR012309; DNA_ligase_ATP-dep_C.
DR   InterPro; IPR012310; DNA_ligase_ATP-dep_cent.
DR   InterPro; IPR016059; DNA_ligase_ATP-dep_CS.
DR   InterPro; IPR012308; DNA_ligase_ATP-dep_N.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   Pfam; PF04679; DNA_ligase_A_C; 1.
DR   Pfam; PF01068; DNA_ligase_A_M; 1.
DR   Pfam; PF04675; DNA_ligase_A_N; 1.
DR   SUPFAM; SSF117018; SSF117018; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   TIGRFAMs; TIGR00574; dnl1; 1.
DR   PROSITE; PS00697; DNA_LIGASE_A1; 1.
DR   PROSITE; PS00333; DNA_LIGASE_A2; 1.
DR   PROSITE; PS50160; DNA_LIGASE_A3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell cycle; Cell division; Complete proteome; DNA damage;
KW   DNA recombination; DNA repair; DNA replication; Isopeptide bond;
KW   Ligase; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN         1    919       DNA ligase 1.
FT                                /FTId=PRO_0000059570.
FT   REGION      449    458       Interaction with target DNA.
FT   REGION      642    644       Interaction with target DNA.
FT   ACT_SITE    568    568       N6-AMP-lysine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10135}.
FT   METAL       621    621       Magnesium 1. {ECO:0000305}.
FT   METAL       720    720       Magnesium 2. {ECO:0000305}.
FT   BINDING     566    566       ATP. {ECO:0000244|PDB:1X9N,
FT                                ECO:0000269|PubMed:15565146}.
FT   BINDING     573    573       ATP. {ECO:0000244|PDB:1X9N,
FT                                ECO:0000269|PubMed:15565146}.
FT   BINDING     589    589       ATP.
FT   BINDING     725    725       ATP. {ECO:0000244|PDB:1X9N,
FT                                ECO:0000269|PubMed:15565146}.
FT   BINDING     738    738       ATP. {ECO:0000250}.
FT   BINDING     744    744       ATP. {ECO:0000244|PDB:1X9N,
FT                                ECO:0000269|PubMed:15565146}.
FT   SITE        305    305       Interaction with target DNA.
FT   SITE        590    590       Interaction with target DNA.
FT   SITE        770    770       Interaction with target DNA.
FT   SITE        795    795       Interaction with target DNA.
FT   MOD_RES      47     47       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      49     49       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES      51     51       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      66     66       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:17693683,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      76     76       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:17693683,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     141    141       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     195    195       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     199    199       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     201    201       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     207    207       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     226    226       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P37913}.
FT   MOD_RES     229    229       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     230    230       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     233    233       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES     798    798       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     801    801       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     819    819       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     911    911       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     913    913       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   CROSSLNK    422    422       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:18655026}.
FT   VAR_SEQ       7     36       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057320.
FT   VAR_SEQ     153    153       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057321.
FT   VAR_SEQ     796    801       LGTGFS -> VLGNWG (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056139.
FT   VAR_SEQ     802    919       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056140.
FT   VARIANT      24     24       A -> V (in dbSNP:rs3730855).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_018802.
FT   VARIANT      52     52       P -> L (in dbSNP:rs4987181).
FT                                /FTId=VAR_020194.
FT   VARIANT      62     62       R -> W (in dbSNP:rs3730863).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_018803.
FT   VARIANT      72     72       D -> G (in dbSNP:rs4987070).
FT                                /FTId=VAR_020195.
FT   VARIANT     152    152       K -> E (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs780748107).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036511.
FT   VARIANT     249    249       G -> E (in dbSNP:rs3730911).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_016766.
FT   VARIANT     267    267       N -> S (in dbSNP:rs3730933).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_016767.
FT   VARIANT     349    349       V -> M (in dbSNP:rs3730947).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_018804.
FT   VARIANT     369    369       V -> I (in dbSNP:rs3730966).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_018805.
FT   VARIANT     409    409       R -> H (in dbSNP:rs4987068).
FT                                /FTId=VAR_016768.
FT   VARIANT     480    480       M -> V (in dbSNP:rs3730980).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_016769.
FT   VARIANT     566    566       E -> K (found in a patient with a
FT                                syndrome of immunodeficiency and
FT                                increased cellular sensitivity to DNA-
FT                                damaging agents due to LIG1 deficiency;
FT                                compound heterozygote carrying W-771;
FT                                dbSNP:rs121434560).
FT                                {ECO:0000269|PubMed:1581963}.
FT                                /FTId=VAR_002262.
FT   VARIANT     612    612       S -> L (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs780324684).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036512.
FT   VARIANT     614    614       T -> I (in dbSNP:rs3731003).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_016770.
FT   VARIANT     677    677       R -> L (in dbSNP:rs3731008).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_018806.
FT   VARIANT     771    771       R -> W (found in a patient with a
FT                                syndrome of immunodeficiency and
FT                                increased cellular sensitivity to DNA-
FT                                damaging agents due to LIG1 deficiency;
FT                                compound heterozygote carrying K-566;
FT                                dbSNP:rs121434561).
FT                                {ECO:0000269|PubMed:1581963}.
FT                                /FTId=VAR_002263.
FT   HELIX       263    265       {ECO:0000244|PDB:1X9N}.
FT   HELIX       275    278       {ECO:0000244|PDB:1X9N}.
FT   HELIX       289    300       {ECO:0000244|PDB:1X9N}.
FT   HELIX       305    322       {ECO:0000244|PDB:1X9N}.
FT   HELIX       324    326       {ECO:0000244|PDB:1X9N}.
FT   HELIX       327    335       {ECO:0000244|PDB:1X9N}.
FT   HELIX       341    343       {ECO:0000244|PDB:1X9N}.
FT   HELIX       351    362       {ECO:0000244|PDB:1X9N}.
FT   HELIX       366    376       {ECO:0000244|PDB:1X9N}.
FT   HELIX       379    382       {ECO:0000244|PDB:1X9N}.
FT   HELIX       401    413       {ECO:0000244|PDB:1X9N}.
FT   HELIX       419    433       {ECO:0000244|PDB:1X9N}.
FT   HELIX       438    446       {ECO:0000244|PDB:1X9N}.
FT   HELIX       456    469       {ECO:0000244|PDB:1X9N}.
FT   TURN        483    486       {ECO:0000244|PDB:1X9N}.
FT   HELIX       489    509       {ECO:0000244|PDB:1X9N}.
FT   HELIX       513    527       {ECO:0000244|PDB:1X9N}.
FT   HELIX       529    531       {ECO:0000244|PDB:1X9N}.
FT   STRAND      544    550       {ECO:0000244|PDB:1X9N}.
FT   HELIX       551    557       {ECO:0000244|PDB:1X9N}.
FT   TURN        558    560       {ECO:0000244|PDB:1X9N}.
FT   STRAND      563    578       {ECO:0000244|PDB:1X9N}.
FT   STRAND      584    587       {ECO:0000244|PDB:1X9N}.
FT   TURN        595    597       {ECO:0000244|PDB:1X9N}.
FT   HELIX       599    603       {ECO:0000244|PDB:1X9N}.
FT   HELIX       606    608       {ECO:0000244|PDB:1X9N}.
FT   STRAND      616    625       {ECO:0000244|PDB:1X9N}.
FT   TURN        627    629       {ECO:0000244|PDB:1X9N}.
FT   HELIX       635    638       {ECO:0000244|PDB:1X9N}.
FT   HELIX       648    650       {ECO:0000244|PDB:1X9N}.
FT   STRAND      653    665       {ECO:0000244|PDB:1X9N}.
FT   HELIX       675    685       {ECO:0000244|PDB:1X9N}.
FT   TURN        690    692       {ECO:0000244|PDB:1X9N}.
FT   STRAND      693    695       {ECO:0000244|PDB:1X9N}.
FT   HELIX       704    716       {ECO:0000244|PDB:1X9N}.
FT   STRAND      718    730       {ECO:0000244|PDB:1X9N}.
FT   TURN        735    737       {ECO:0000244|PDB:1X9N}.
FT   STRAND      739    746       {ECO:0000244|PDB:1X9N}.
FT   HELIX       747    751       {ECO:0000244|PDB:1X9N}.
FT   STRAND      755    767       {ECO:0000244|PDB:1X9N}.
FT   STRAND      774    784       {ECO:0000244|PDB:1X9N}.
FT   TURN        785    788       {ECO:0000244|PDB:1X9N}.
FT   STRAND      789    796       {ECO:0000244|PDB:1X9N}.
FT   HELIX       802    814       {ECO:0000244|PDB:1X9N}.
FT   STRAND      816    819       {ECO:0000244|PDB:1X9N}.
FT   STRAND      827    829       {ECO:0000244|PDB:1X9N}.
FT   STRAND      833    836       {ECO:0000244|PDB:1X9N}.
FT   STRAND      841    854       {ECO:0000244|PDB:1X9N}.
FT   TURN        857    861       {ECO:0000244|PDB:1X9N}.
FT   STRAND      867    872       {ECO:0000244|PDB:1X9N}.
FT   STRAND      874    878       {ECO:0000244|PDB:1X9N}.
FT   HELIX       884    886       {ECO:0000244|PDB:1X9N}.
FT   HELIX       890    900       {ECO:0000244|PDB:1X9N}.
SQ   SEQUENCE   919 AA;  101736 MW;  B2854DAE38A8D4AD CRC64;
     MQRSIMSFFH PKKEGKAKKP EKEASNSSRE TEPPPKAALK EWNGVVSESD SPVKRPGRKA
     ARVLGSEGEE EDEALSPAKG QKPALDCSQV SPPRPATSPE NNASLSDTSP MDSSPSGIPK
     RRTARKQLPK RTIQEVLEEQ SEDEDREAKR KKEEEEEETP KESLTEAEVA TEKEGEDGDQ
     PTTPPKPLKT SKAETPTESV SEPEVATKQE LQEEEEQTKP PRRAPKTLSS FFTPRKPAVK
     KEVKEEEPGA PGKEGAAEGP LDPSGYNPAK NNYHPVEDAC WKPGQKVPYL AVARTFEKIE
     EVSARLRMVE TLSNLLRSVV ALSPPDLLPV LYLSLNHLGP PQQGLELGVG DGVLLKAVAQ
     ATGRQLESVR AEAAEKGDVG LVAENSRSTQ RLMLPPPPLT ASGVFSKFRD IARLTGSAST
     AKKIDIIKGL FVACRHSEAR FIARSLSGRL RLGLAEQSVL AALSQAVSLT PPGQEFPPAM
     VDAGKGKTAE ARKTWLEEQG MILKQTFCEV PDLDRIIPVL LEHGLERLPE HCKLSPGIPL
     KPMLAHPTRG ISEVLKRFEE AAFTCEYKYD GQRAQIHALE GGEVKIFSRN QEDNTGKYPD
     IISRIPKIKL PSVTSFILDT EAVAWDREKK QIQPFQVLTT RKRKEVDASE IQVQVCLYAF
     DLIYLNGESL VREPLSRRRQ LLRENFVETE GEFVFATSLD TKDIEQIAEF LEQSVKDSCE
     GLMVKTLDVD ATYEIAKRSH NWLKLKKDYL DGVGDTLDLV VIGAYLGRGK RAGRYGGFLL
     ASYDEDSEEL QAICKLGTGF SDEELEEHHQ SLKALVLPSP RPYVRIDGAV IPDHWLDPSA
     VWEVKCADLS LSPIYPAARG LVDSDKGISL RFPRFIRVRE DKQPEQATTS AQVACLYRKQ
     SQIQNQQGED SGSDPEDTY
//
ID   DNLI3_HUMAN             Reviewed;        1009 AA.
AC   P49916; E5KLB5; E5KLB6; Q16714; Q6NVK3;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   07-JUL-2009, sequence version 2.
DT   06-JUL-2016, entry version 181.
DE   RecName: Full=DNA ligase 3;
DE            EC=6.5.1.1 {ECO:0000269|PubMed:10207110, ECO:0000269|PubMed:20518483};
DE   AltName: Full=DNA ligase III;
DE   AltName: Full=Polydeoxyribonucleotide synthase [ATP] 3;
DE   Flags: Precursor;
GN   Name=LIG3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND INTERACTION WITH XRCC1.
RC   TISSUE=Prostate;
RX   PubMed=7760816;
RA   Wei Y.-F., Robins P., Carter K., Caldecott K., Pappin D.J.C.,
RA   Yu G.-L., Wang R.-P., Shell B.K., Nash R.A., Schar P., Barnes D.E.,
RA   Haseltine W.A., Lindahl T.;
RT   "Molecular cloning and expression of human cDNAs encoding a novel DNA
RT   ligase IV and DNA ligase III, an enzyme active in DNA repair and
RT   recombination.";
RL   Mol. Cell. Biol. 15:3206-3216(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=7565692;
RA   Chen J., Tomkinson A.E., Ramos W., Mackey Z.B., Danehower S.,
RA   Walter C.A., Schultz R.A., Besterman J.M., Husain I.;
RT   "Mammalian DNA ligase III: molecular cloning, chromosomal
RT   localization, and expression in spermatocytes undergoing meiotic
RT   recombination.";
RL   Mol. Cell. Biol. 15:5412-5422(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-768.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W.,
RA   Mindrinos M., Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-867.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND ALTERNATIVE
RP   INITIATION.
RX   PubMed=10207110;
RA   Lakshmipathy U., Campbell C.;
RT   "The human DNA ligase III gene encodes nuclear and mitochondrial
RT   proteins.";
RL   Mol. Cell. Biol. 19:3869-3876(1999).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210; SER-216; SER-242
RP   AND SER-913, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24674627; DOI=10.1016/j.dnarep.2014.01.015;
RA   Akbari M., Keijzers G., Maynard S., Scheibye-Knudsen M., Desler C.,
RA   Hickson I.D., Bohr V.A.;
RT   "Overexpression of DNA ligase III in mitochondria protects cells
RT   against oxidative stress and improves mitochondrial DNA base excision
RT   repair.";
RL   DNA Repair 16:44-53(2014).
RN   [19]
RP   STRUCTURE BY NMR OF 924-1009.
RX   PubMed=11281714; DOI=10.1006/prep.2001.1391;
RA   Thornton K.H., Krishnan V.V., West M.G., Popham J., Ramirez M.,
RA   Thelen M.P., Cosman M.;
RT   "Expression, purification, and biophysical characterization of the
RT   BRCT domain of human DNA ligase IIIalpha.";
RL   Protein Expr. Purif. 21:401-411(2001).
RN   [20]
RP   STRUCTURE BY NMR OF 1-204 IN COMPLEX WITH ZINC.
RX   PubMed=15288782; DOI=10.1016/j.jmb.2004.06.035;
RA   Kulczyk A.W., Yang J.C., Neuhaus D.;
RT   "Solution structure and DNA binding of the zinc-finger domain from DNA
RT   ligase IIIalpha.";
RL   J. Mol. Biol. 341:723-738(2004).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 257-833 IN COMPLEX WITH DNA
RP   AND AMP, ACTIVE SITE, FUNCTION, CATALYTIC ACTIVITY, DOMAIN, AND
RP   MUTAGENESIS OF LYS-410 AND ARG-414.
RX   PubMed=20518483; DOI=10.1021/bi100503w;
RA   Cotner-Gohara E., Kim I.K., Hammel M., Tainer J.A., Tomkinson A.E.,
RA   Ellenberger T.;
RT   "Human DNA ligase III recognizes DNA ends by dynamic switching between
RT   two DNA-bound states.";
RL   Biochemistry 49:6165-6176(2010).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 924-1009 IN COMPLEX WITH
RP   XRCC1, AND INTERACTION WITH XRCC1.
RX   PubMed=21652643; DOI=10.1093/nar/gkr419;
RA   Cuneo M.J., Gabel S.A., Krahn J.M., Ricker M.A., London R.E.;
RT   "The structural basis for partitioning of the XRCC1/DNA ligase III-?
RT   BRCT-mediated dimer complexes.";
RL   Nucleic Acids Res. 39:7816-7827(2011).
RN   [23]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-717.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Isoform 3 functions as heterodimer with DNA-repair
CC       protein XRCC1 in the nucleus and can correct defective DNA strand-
CC       break repair and sister chromatid exchange following treatment
CC       with ionizing radiation and alkylating agents. Isoform 1 is
CC       targeted to mitochondria, where it functions as DNA ligase in
CC       mitochondrial base-excision DNA repair (PubMed:10207110,
CC       PubMed:24674627). {ECO:0000269|PubMed:10207110,
CC       ECO:0000269|PubMed:24674627}.
CC   -!- CATALYTIC ACTIVITY: ATP + (deoxyribonucleotide)(n) +
CC       (deoxyribonucleotide)(m) = AMP + diphosphate +
CC       (deoxyribonucleotide)(n+m). {ECO:0000255|PROSITE-ProRule:PRU10135,
CC       ECO:0000269|PubMed:10207110, ECO:0000269|PubMed:20518483}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Isoform 3 interacts (via BRCT domain) with the nuclear
CC       DNA-repair protein XRCC1. {ECO:0000269|PubMed:21652643,
CC       ECO:0000269|PubMed:7760816}.
CC   -!- INTERACTION:
CC       P61244:MAX; NbExp=2; IntAct=EBI-1753381, EBI-751711;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Mitochondrion
CC       {ECO:0000269|PubMed:10207110, ECO:0000269|PubMed:24674627}.
CC       Note=Contains an N-terminal mitochondrial transit peptide.
CC       {ECO:0000269|PubMed:10207110}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Mitochondrion
CC       {ECO:0000305|PubMed:10207110}. Note=Contains an N-terminal
CC       mitochondrial transit peptide. {ECO:0000305|PubMed:10207110}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Nucleus
CC       {ECO:0000269|PubMed:10207110}. Note=Lacks the N-terminal
CC       mitochondrial transit peptide. {ECO:0000269|PubMed:10207110}.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Nucleus
CC       {ECO:0000305|PubMed:10207110}. Note=Lacks the N-terminal
CC       mitochondrial transit peptide. {ECO:0000305|PubMed:10207110}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=4;
CC       Name=1;
CC         IsoId=P49916-1; Sequence=Displayed;
CC         Note=Produced by alternative splicing.;
CC       Name=2;
CC         IsoId=P49916-2; Sequence=VSP_001302;
CC         Note=Produced by alternative splicing.;
CC       Name=3; Synonyms=Alpha;
CC         IsoId=P49916-3; Sequence=VSP_057464;
CC         Note=Produced by alternative initiation of isoform 1.;
CC       Name=4; Synonyms=Beta;
CC         IsoId=P49916-4; Sequence=VSP_057464, VSP_001302;
CC         Note=Produced by alternative initiation of isoform 2.;
CC   -!- TISSUE SPECIFICITY: Testis, thymus, prostate and heart.
CC   -!- DOMAIN: The PARP-type zinc finger is required for DNA ligase
CC       activity. {ECO:0000269|PubMed:20518483}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent DNA ligase family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 BRCT domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00033}.
CC   -!- SIMILARITY: Contains 1 PARP-type zinc finger.
CC       {ECO:0000255|PROSITE-ProRule:PRU00264}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=DNA ligase entry;
CC       URL="https://en.wikipedia.org/wiki/DNA_ligase";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/mpg/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X84740; CAA59230.1; -; mRNA.
DR   EMBL; U40671; AAA85022.1; -; mRNA.
DR   EMBL; HQ204826; ADP89974.1; -; Genomic_DNA.
DR   EMBL; HQ204826; ADP89975.1; -; Genomic_DNA.
DR   EMBL; HQ204827; ADP89976.1; -; Genomic_DNA.
DR   EMBL; HQ204827; ADP89977.1; -; Genomic_DNA.
DR   EMBL; HQ204828; ADP89978.1; -; Genomic_DNA.
DR   EMBL; HQ204828; ADP89979.1; -; Genomic_DNA.
DR   EMBL; HQ204829; ADP89980.1; -; Genomic_DNA.
DR   EMBL; HQ204829; ADP89981.1; -; Genomic_DNA.
DR   EMBL; HQ204830; ADP89982.1; -; Genomic_DNA.
DR   EMBL; HQ204830; ADP89983.1; -; Genomic_DNA.
DR   EMBL; HQ204831; ADP89984.1; -; Genomic_DNA.
DR   EMBL; HQ204831; ADP89985.1; -; Genomic_DNA.
DR   EMBL; HQ204832; ADP89986.1; -; Genomic_DNA.
DR   EMBL; HQ204832; ADP89987.1; -; Genomic_DNA.
DR   EMBL; HQ204833; ADP89988.1; -; Genomic_DNA.
DR   EMBL; HQ204833; ADP89989.1; -; Genomic_DNA.
DR   EMBL; HQ204834; ADP89990.1; -; Genomic_DNA.
DR   EMBL; HQ204834; ADP89991.1; -; Genomic_DNA.
DR   EMBL; HQ204835; ADP89992.1; -; Genomic_DNA.
DR   EMBL; HQ204835; ADP89993.1; -; Genomic_DNA.
DR   EMBL; HQ204836; ADP89994.1; -; Genomic_DNA.
DR   EMBL; HQ204836; ADP89995.1; -; Genomic_DNA.
DR   EMBL; HQ204837; ADP89996.1; -; Genomic_DNA.
DR   EMBL; HQ204837; ADP89997.1; -; Genomic_DNA.
DR   EMBL; HQ204838; ADP89998.1; -; Genomic_DNA.
DR   EMBL; HQ204838; ADP89999.1; -; Genomic_DNA.
DR   EMBL; HQ204839; ADP90000.1; -; Genomic_DNA.
DR   EMBL; HQ204839; ADP90001.1; -; Genomic_DNA.
DR   EMBL; HQ204840; ADP90002.1; -; Genomic_DNA.
DR   EMBL; HQ204840; ADP90003.1; -; Genomic_DNA.
DR   EMBL; HQ204841; ADP90004.1; -; Genomic_DNA.
DR   EMBL; HQ204841; ADP90005.1; -; Genomic_DNA.
DR   EMBL; HQ204842; ADP90006.1; -; Genomic_DNA.
DR   EMBL; HQ204842; ADP90007.1; -; Genomic_DNA.
DR   EMBL; HQ204843; ADP90008.1; -; Genomic_DNA.
DR   EMBL; HQ204843; ADP90009.1; -; Genomic_DNA.
DR   EMBL; HQ204844; ADP90010.1; -; Genomic_DNA.
DR   EMBL; HQ204844; ADP90011.1; -; Genomic_DNA.
DR   EMBL; HQ204845; ADP90012.1; -; Genomic_DNA.
DR   EMBL; HQ204845; ADP90013.1; -; Genomic_DNA.
DR   EMBL; HQ204846; ADP90014.1; -; Genomic_DNA.
DR   EMBL; HQ204846; ADP90015.1; -; Genomic_DNA.
DR   EMBL; HQ204847; ADP90016.1; -; Genomic_DNA.
DR   EMBL; HQ204847; ADP90017.1; -; Genomic_DNA.
DR   EMBL; HQ204848; ADP90018.1; -; Genomic_DNA.
DR   EMBL; HQ204848; ADP90019.1; -; Genomic_DNA.
DR   EMBL; HQ204849; ADP90020.1; -; Genomic_DNA.
DR   EMBL; HQ204849; ADP90021.1; -; Genomic_DNA.
DR   EMBL; HQ204850; ADP90022.1; -; Genomic_DNA.
DR   EMBL; HQ204850; ADP90023.1; -; Genomic_DNA.
DR   EMBL; HQ204851; ADP90024.1; -; Genomic_DNA.
DR   EMBL; HQ204851; ADP90025.1; -; Genomic_DNA.
DR   EMBL; HQ204852; ADP90026.1; -; Genomic_DNA.
DR   EMBL; HQ204852; ADP90027.1; -; Genomic_DNA.
DR   EMBL; HQ204853; ADP90028.1; -; Genomic_DNA.
DR   EMBL; HQ204853; ADP90029.1; -; Genomic_DNA.
DR   EMBL; HQ204854; ADP90030.1; -; Genomic_DNA.
DR   EMBL; HQ204854; ADP90031.1; -; Genomic_DNA.
DR   EMBL; HQ204855; ADP90032.1; -; Genomic_DNA.
DR   EMBL; HQ204855; ADP90033.1; -; Genomic_DNA.
DR   EMBL; HQ204856; ADP90034.1; -; Genomic_DNA.
DR   EMBL; HQ204856; ADP90035.1; -; Genomic_DNA.
DR   EMBL; HQ204857; ADP90036.1; -; Genomic_DNA.
DR   EMBL; HQ204857; ADP90037.1; -; Genomic_DNA.
DR   EMBL; HQ204858; ADP90038.1; -; Genomic_DNA.
DR   EMBL; HQ204858; ADP90039.1; -; Genomic_DNA.
DR   EMBL; HQ204859; ADP90040.1; -; Genomic_DNA.
DR   EMBL; HQ204859; ADP90041.1; -; Genomic_DNA.
DR   EMBL; HQ204860; ADP90042.1; -; Genomic_DNA.
DR   EMBL; HQ204860; ADP90043.1; -; Genomic_DNA.
DR   EMBL; HQ204861; ADP90044.1; -; Genomic_DNA.
DR   EMBL; HQ204861; ADP90045.1; -; Genomic_DNA.
DR   EMBL; HQ204862; ADP90046.1; -; Genomic_DNA.
DR   EMBL; HQ204862; ADP90047.1; -; Genomic_DNA.
DR   EMBL; HQ204863; ADP90048.1; -; Genomic_DNA.
DR   EMBL; HQ204863; ADP90049.1; -; Genomic_DNA.
DR   EMBL; HQ204864; ADP90050.1; -; Genomic_DNA.
DR   EMBL; HQ204864; ADP90051.1; -; Genomic_DNA.
DR   EMBL; HQ204865; ADP90052.1; -; Genomic_DNA.
DR   EMBL; HQ204865; ADP90053.1; -; Genomic_DNA.
DR   EMBL; AF491645; AAL91592.1; -; Genomic_DNA.
DR   EMBL; AC004223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022903; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471147; EAW80197.1; -; Genomic_DNA.
DR   EMBL; CH471147; EAW80199.1; -; Genomic_DNA.
DR   EMBL; BC068005; AAH68005.1; -; mRNA.
DR   CCDS; CCDS11284.2; -. [P49916-1]
DR   CCDS; CCDS11285.2; -. [P49916-2]
DR   PIR; I37292; I37292.
DR   RefSeq; NP_002302.2; NM_002311.4. [P49916-2]
DR   RefSeq; NP_039269.2; NM_013975.3. [P49916-1]
DR   UniGene; Hs.100299; -.
DR   PDB; 1IMO; NMR; -; A=924-1009.
DR   PDB; 1IN1; NMR; -; A=924-1009.
DR   PDB; 1UW0; NMR; -; A=88-204.
DR   PDB; 3L2P; X-ray; 3.00 A; A=257-833.
DR   PDB; 3PC7; X-ray; 1.65 A; A/B=924-1009.
DR   PDB; 3PC8; X-ray; 2.31 A; C/D=924-1008.
DR   PDB; 3QVG; X-ray; 2.26 A; A/C=924-1008.
DR   PDBsum; 1IMO; -.
DR   PDBsum; 1IN1; -.
DR   PDBsum; 1UW0; -.
DR   PDBsum; 3L2P; -.
DR   PDBsum; 3PC7; -.
DR   PDBsum; 3PC8; -.
DR   PDBsum; 3QVG; -.
DR   ProteinModelPortal; P49916; -.
DR   SMR; P49916; 88-204, 257-833, 928-1008.
DR   BioGrid; 110168; 61.
DR   IntAct; P49916; 27.
DR   MINT; MINT-4531178; -.
DR   STRING; 9606.ENSP00000367787; -.
DR   DrugBank; DB00290; Bleomycin.
DR   iPTMnet; P49916; -.
DR   PhosphoSite; P49916; -.
DR   BioMuta; LIG3; -.
DR   DMDM; 251757259; -.
DR   EPD; P49916; -.
DR   MaxQB; P49916; -.
DR   PaxDb; P49916; -.
DR   PeptideAtlas; P49916; -.
DR   PRIDE; P49916; -.
DR   DNASU; 3980; -.
DR   Ensembl; ENST00000262327; ENSP00000262327; ENSG00000005156. [P49916-2]
DR   Ensembl; ENST00000378526; ENSP00000367787; ENSG00000005156. [P49916-1]
DR   GeneID; 3980; -.
DR   KEGG; hsa:3980; -.
DR   UCSC; uc002hij.4; human. [P49916-1]
DR   CTD; 3980; -.
DR   GeneCards; LIG3; -.
DR   HGNC; HGNC:6600; LIG3.
DR   HPA; HPA006723; -.
DR   MIM; 600940; gene.
DR   neXtProt; NX_P49916; -.
DR   PharmGKB; PA30374; -.
DR   eggNOG; KOG4437; Eukaryota.
DR   eggNOG; COG1793; LUCA.
DR   GeneTree; ENSGT00840000129855; -.
DR   HOGENOM; HOG000007653; -.
DR   HOVERGEN; HBG005515; -.
DR   InParanoid; P49916; -.
DR   KO; K10776; -.
DR   OMA; DCIYFNG; -.
DR   OrthoDB; EOG7BKCT2; -.
DR   PhylomeDB; P49916; -.
DR   TreeFam; TF316220; -.
DR   BRENDA; 6.5.1.1; 2681.
DR   Reactome; R-HSA-110381; Resolution of AP sites via the single-nucleotide replacement pathway.
DR   Reactome; R-HSA-5649702; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway.
DR   Reactome; R-HSA-5685939; HDR through MMEJ (alt-NHEJ).
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   SIGNOR; P49916; -.
DR   ChiTaRS; LIG3; human.
DR   EvolutionaryTrace; P49916; -.
DR   GeneWiki; LIG3; -.
DR   GenomeRNAi; 3980; -.
DR   PRO; PR:P49916; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; P49916; -.
DR   CleanEx; HS_LIG3; -.
DR   ExpressionAtlas; P49916; baseline and differential.
DR   Genevisible; P49916; HS.
DR   GO; GO:0070421; C:DNA ligase III-XRCC1 complex; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003910; F:DNA ligase (ATP) activity; IDA:BHF-UCL.
DR   GO; GO:0003909; F:DNA ligase activity; IDA:BHF-UCL.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006288; P:base-excision repair, DNA ligation; IDA:BHF-UCL.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071897; P:DNA biosynthetic process; IEA:InterPro.
DR   GO; GO:0006266; P:DNA ligation; IDA:BHF-UCL.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0006302; P:double-strand break repair; IDA:BHF-UCL.
DR   GO; GO:0097681; P:double-strand break repair via alternative nonhomologous end joining; IGI:BHF-UCL.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; TAS:Reactome.
DR   GO; GO:0043504; P:mitochondrial DNA repair; IMP:BHF-UCL.
DR   GO; GO:0007005; P:mitochondrion organization; IDA:BHF-UCL.
DR   GO; GO:0090298; P:negative regulation of mitochondrial DNA replication; IMP:CACAO.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   Gene3D; 1.10.3260.10; -; 1.
DR   Gene3D; 2.40.50.140; -; 1.
DR   Gene3D; 3.30.1740.10; -; 1.
DR   Gene3D; 3.40.50.10190; -; 1.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR000977; DNA_ligase_ATP-dep.
DR   InterPro; IPR012309; DNA_ligase_ATP-dep_C.
DR   InterPro; IPR012310; DNA_ligase_ATP-dep_cent.
DR   InterPro; IPR016059; DNA_ligase_ATP-dep_CS.
DR   InterPro; IPR012308; DNA_ligase_ATP-dep_N.
DR   InterPro; IPR031916; LIG3_BRCT.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR001510; Znf_PARP.
DR   Pfam; PF04679; DNA_ligase_A_C; 1.
DR   Pfam; PF01068; DNA_ligase_A_M; 1.
DR   Pfam; PF04675; DNA_ligase_A_N; 1.
DR   Pfam; PF16759; LIG3_BRCT; 1.
DR   Pfam; PF00645; zf-PARP; 1.
DR   SMART; SM00292; BRCT; 1.
DR   SMART; SM01336; zf-PARP; 1.
DR   SUPFAM; SSF117018; SSF117018; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   SUPFAM; SSF52113; SSF52113; 1.
DR   TIGRFAMs; TIGR00574; dnl1; 1.
DR   PROSITE; PS50172; BRCT; 1.
DR   PROSITE; PS00697; DNA_LIGASE_A1; 1.
DR   PROSITE; PS00333; DNA_LIGASE_A2; 1.
DR   PROSITE; PS50160; DNA_LIGASE_A3; 1.
DR   PROSITE; PS00347; PARP_ZN_FINGER_1; 1.
DR   PROSITE; PS50064; PARP_ZN_FINGER_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Alternative splicing;
KW   ATP-binding; Cell cycle; Cell division; Complete proteome; DNA damage;
KW   DNA recombination; DNA repair; DNA replication; Ligase; Magnesium;
KW   Metal-binding; Mitochondrion; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transit peptide;
KW   Zinc; Zinc-finger.
FT   TRANSIT       1     42       Mitochondrion. {ECO:0000255}.
FT   CHAIN        43   1009       DNA ligase 3.
FT                                /FTId=PRO_0000059574.
FT   DOMAIN      933   1009       BRCT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   ZN_FING      93    185       PARP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00264,
FT                                ECO:0000269|PubMed:15288782}.
FT   REGION      277    280       Interaction with DNA.
FT                                {ECO:0000269|PubMed:20518483}.
FT   REGION      318    323       Interaction with DNA.
FT                                {ECO:0000269|PubMed:20518483}.
FT   REGION      388    391       Interaction with DNA.
FT                                {ECO:0000269|PubMed:20518483}.
FT   REGION      421    427       Interaction with DNA.
FT                                {ECO:0000269|PubMed:20518483}.
FT   ACT_SITE    508    508       N6-AMP-lysine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10135,
FT                                ECO:0000269|PubMed:20518483}.
FT   METAL       560    560       Magnesium 1. {ECO:0000250}.
FT   METAL       655    655       Magnesium 2. {ECO:0000250}.
FT   BINDING     506    506       ATP. {ECO:0000244|PDB:3L2P, ECO:0000305}.
FT   BINDING     513    513       ATP. {ECO:0000244|PDB:3L2P, ECO:0000305}.
FT   BINDING     528    528       ATP. {ECO:0000250}.
FT   BINDING     660    660       ATP. {ECO:0000244|PDB:3L2P, ECO:0000305}.
FT   BINDING     671    671       ATP. {ECO:0000250}.
FT   BINDING     675    675       ATP. {ECO:0000250}.
FT   MOD_RES     210    210       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     216    216       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     227    227       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     242    242       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     913    913       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     87       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_057464.
FT   VAR_SEQ     933   1009       VLLDIFTGVRLYLPPSTPDFSRLRRYFVAFDGDLVQEFDMT
FT                                SATHVLGSRDKNPAAQQVSPEWIWACIRKRRLVAPC -> R
FT                                RPASEQRGRTVPAGRR (in isoform 2 and
FT                                isoform 4). {ECO:0000303|PubMed:7565692,
FT                                ECO:0000305}.
FT                                /FTId=VSP_001302.
FT   VARIANT     224    224       R -> W (in dbSNP:rs3744356).
FT                                /FTId=VAR_020196.
FT   VARIANT     717    717       D -> N (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs757797167).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036513.
FT   VARIANT     768    768       Y -> H (in dbSNP:rs200981995).
FT                                {ECO:0000269|PubMed:20843780}.
FT                                /FTId=VAR_072387.
FT   VARIANT     867    867       R -> H (in dbSNP:rs3136025).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018807.
FT   VARIANT     898    898       K -> T (in dbSNP:rs4986974).
FT                                /FTId=VAR_021938.
FT   VARIANT     986    986       P -> S (in dbSNP:rs4986973).
FT                                /FTId=VAR_020197.
FT   MUTAGEN     410    410       K->E: Nearly abolishes ligase activity
FT                                with blunt-ended DNA, but not with nicked
FT                                DNA. {ECO:0000269|PubMed:20518483}.
FT   MUTAGEN     414    414       R->E: Abolishes ligase activity with
FT                                blunt-ended DNA, but not with nicked DNA.
FT                                {ECO:0000269|PubMed:20518483}.
FT   STRAND       92     97       {ECO:0000244|PDB:1UW0}.
FT   STRAND      117    124       {ECO:0000244|PDB:1UW0}.
FT   HELIX       140    149       {ECO:0000244|PDB:1UW0}.
FT   STRAND      152    154       {ECO:0000244|PDB:1UW0}.
FT   STRAND      161    165       {ECO:0000244|PDB:1UW0}.
FT   TURN        166    168       {ECO:0000244|PDB:1UW0}.
FT   HELIX       171    185       {ECO:0000244|PDB:1UW0}.
FT   STRAND      188    190       {ECO:0000244|PDB:1UW0}.
FT   HELIX       259    261       {ECO:0000244|PDB:3L2P}.
FT   HELIX       263    274       {ECO:0000244|PDB:3L2P}.
FT   HELIX       279    291       {ECO:0000244|PDB:3L2P}.
FT   HELIX       303    310       {ECO:0000244|PDB:3L2P}.
FT   TURN        312    314       {ECO:0000244|PDB:3L2P}.
FT   HELIX       323    334       {ECO:0000244|PDB:3L2P}.
FT   HELIX       338    344       {ECO:0000244|PDB:3L2P}.
FT   HELIX       345    347       {ECO:0000244|PDB:3L2P}.
FT   HELIX       350    359       {ECO:0000244|PDB:3L2P}.
FT   STRAND      362    364       {ECO:0000244|PDB:3L2P}.
FT   HELIX       374    385       {ECO:0000244|PDB:3L2P}.
FT   HELIX       390    401       {ECO:0000244|PDB:3L2P}.
FT   HELIX       407    416       {ECO:0000244|PDB:3L2P}.
FT   STRAND      421    423       {ECO:0000244|PDB:3L2P}.
FT   HELIX       426    431       {ECO:0000244|PDB:3L2P}.
FT   HELIX       437    443       {ECO:0000244|PDB:3L2P}.
FT   HELIX       447    459       {ECO:0000244|PDB:3L2P}.
FT   STRAND      485    488       {ECO:0000244|PDB:3L2P}.
FT   HELIX       492    498       {ECO:0000244|PDB:3L2P}.
FT   STRAND      503    507       {ECO:0000244|PDB:3L2P}.
FT   STRAND      511    519       {ECO:0000244|PDB:3L2P}.
FT   STRAND      522    526       {ECO:0000244|PDB:3L2P}.
FT   HELIX       535    537       {ECO:0000244|PDB:3L2P}.
FT   TURN        538    540       {ECO:0000244|PDB:3L2P}.
FT   HELIX       541    543       {ECO:0000244|PDB:3L2P}.
FT   HELIX       545    548       {ECO:0000244|PDB:3L2P}.
FT   STRAND      553    564       {ECO:0000244|PDB:3L2P}.
FT   TURN        566    568       {ECO:0000244|PDB:3L2P}.
FT   HELIX       574    577       {ECO:0000244|PDB:3L2P}.
FT   HELIX       579    584       {ECO:0000244|PDB:3L2P}.
FT   STRAND      590    600       {ECO:0000244|PDB:3L2P}.
FT   HELIX       610    620       {ECO:0000244|PDB:3L2P}.
FT   TURN        625    627       {ECO:0000244|PDB:3L2P}.
FT   STRAND      628    630       {ECO:0000244|PDB:3L2P}.
FT   STRAND      633    636       {ECO:0000244|PDB:3L2P}.
FT   HELIX       639    651       {ECO:0000244|PDB:3L2P}.
FT   STRAND      657    663       {ECO:0000244|PDB:3L2P}.
FT   STRAND      671    676       {ECO:0000244|PDB:3L2P}.
FT   TURN        678    680       {ECO:0000244|PDB:3L2P}.
FT   STRAND      688    698       {ECO:0000244|PDB:3L2P}.
FT   STRAND      710    716       {ECO:0000244|PDB:3L2P}.
FT   TURN        718    720       {ECO:0000244|PDB:3L2P}.
FT   STRAND      721    729       {ECO:0000244|PDB:3L2P}.
FT   HELIX       735    740       {ECO:0000244|PDB:3L2P}.
FT   TURN        741    743       {ECO:0000244|PDB:3L2P}.
FT   STRAND      780    787       {ECO:0000244|PDB:3L2P}.
FT   STRAND      789    791       {ECO:0000244|PDB:3L2P}.
FT   STRAND      795    797       {ECO:0000244|PDB:3L2P}.
FT   STRAND      800    804       {ECO:0000244|PDB:3L2P}.
FT   STRAND      816    819       {ECO:0000244|PDB:3L2P}.
FT   HELIX       822    830       {ECO:0000244|PDB:3L2P}.
FT   HELIX       924    927       {ECO:0000244|PDB:1IMO}.
FT   TURN        930    932       {ECO:0000244|PDB:3QVG}.
FT   STRAND      936    938       {ECO:0000244|PDB:1IMO}.
FT   STRAND      942    944       {ECO:0000244|PDB:3QVG}.
FT   HELIX       952    961       {ECO:0000244|PDB:3PC7}.
FT   HELIX       969    974       {ECO:0000244|PDB:3PC7}.
FT   STRAND      976    980       {ECO:0000244|PDB:3PC7}.
FT   STRAND      982    984       {ECO:0000244|PDB:3QVG}.
FT   STRAND      988    991       {ECO:0000244|PDB:3PC7}.
FT   HELIX       993   1002       {ECO:0000244|PDB:3PC7}.
SQ   SEQUENCE   1009 AA;  112907 MW;  0E4057E33C3F19A6 CRC64;
     MSLAFKIFFP QTLRALSRKE LCLFRKHHWR DVRQFSQWSE TDLLHGHPLF LRRKPVLSFQ
     GSHLRSRATY LVFLPGLHVG LCSGPCEMAE QRFCVDYAKR GTAGCKKCKE KIVKGVCRIG
     KVVPNPFSES GGDMKEWYHI KCMFEKLERA RATTKKIEDL TELEGWEELE DNEKEQITQH
     IADLSSKAAG TPKKKAVVQA KLTTTGQVTS PVKGASFVTS TNPRKFSGFS AKPNNSGEAP
     SSPTPKRSLS SSKCDPRHKD CLLREFRKLC AMVADNPSYN TKTQIIQDFL RKGSAGDGFH
     GDVYLTVKLL LPGVIKTVYN LNDKQIVKLF SRIFNCNPDD MARDLEQGDV SETIRVFFEQ
     SKSFPPAAKS LLTIQEVDEF LLRLSKLTKE DEQQQALQDI ASRCTANDLK CIIRLIKHDL
     KMNSGAKHVL DALDPNAYEA FKASRNLQDV VERVLHNAQE VEKEPGQRRA LSVQASLMTP
     VQPMLAEACK SVEYAMKKCP NGMFSEIKYD GERVQVHKNG DHFSYFSRSL KPVLPHKVAH
     FKDYIPQAFP GGHSMILDSE VLLIDNKTGK PLPFGTLGVH KKAAFQDANV CLFVFDCIYF
     NDVSLMDRPL CERRKFLHDN MVEIPNRIMF SEMKRVTKAL DLADMITRVI QEGLEGLVLK
     DVKGTYEPGK RHWLKVKKDY LNEGAMADTA DLVVLGAFYG QGSKGGMMSI FLMGCYDPGS
     QKWCTVTKCA GGHDDATLAR LQNELDMVKI SKDPSKIPSW LKVNKIYYPD FIVPDPKKAA
     VWEITGAEFS KSEAHTADGI SIRFPRCTRI RDDKDWKSAT NLPQLKELYQ LSKEKADFTV
     VAGDEGSSTT GGSSEENKGP SGSAVSRKAP SKPSASTKKA EGKLSNSNSK DGNMQTAKPS
     AMKVGEKLAT KSSPVKVGEK RKAADETLCQ TKVLLDIFTG VRLYLPPSTP DFSRLRRYFV
     AFDGDLVQEF DMTSATHVLG SRDKNPAAQQ VSPEWIWACI RKRRLVAPC
//
ID   DNLI4_HUMAN             Reviewed;         911 AA.
AC   P49917; Q8IY66; Q8TEU5;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   07-FEB-2006, sequence version 2.
DT   16-JAN-2019, entry version 206.
DE   RecName: Full=DNA ligase 4;
DE            EC=6.5.1.1 {ECO:0000255|PROSITE-ProRule:PRU10135};
DE   AltName: Full=DNA ligase IV;
DE   AltName: Full=Polydeoxyribonucleotide synthase [ATP] 4;
GN   Name=LIG4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Prostate;
RX   PubMed=7760816; DOI=10.1128/MCB.15.6.3206;
RA   Wei Y.-F., Robins P., Carter K., Caldecott K., Pappin D.J.C.,
RA   Yu G.-L., Wang R.-P., Shell B.K., Nash R.A., Schar P., Barnes D.E.,
RA   Haseltine W.A., Lindahl T.;
RT   "Molecular cloning and expression of human cDNAs encoding a novel DNA
RT   ligase IV and DNA ligase III, an enzyme active in DNA repair and
RT   recombination.";
RL   Mol. Cell. Biol. 15:3206-3216(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-231 AND THR-857.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   CHARACTERIZATION.
RX   PubMed=8798671; DOI=10.1074/jbc.271.39.24257;
RA   Robins P., Lindahl T.;
RT   "DNA ligase IV from HeLa cell nuclei.";
RL   J. Biol. Chem. 271:24257-24261(1996).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH XRCC4.
RX   PubMed=9809069; DOI=10.1016/S1097-2765(00)80147-1;
RA   Grawunder U., Zimmer D., Fugmann S., Schwarz K., Lieber M.R.;
RT   "DNA ligase IV is essential for V(D)J recombination and DNA double-
RT   strand break repair in human precursor lymphocytes.";
RL   Mol. Cell 2:477-484(1998).
RN   [7]
RP   INTERACTION WITH XRCC4.
RX   PubMed=9259561; DOI=10.1016/S0960-9822(06)00258-2;
RA   Critchlow S.E., Bowater R.P., Jackson S.P.;
RT   "Mammalian DNA double-strand break repair protein XRCC4 interacts with
RT   DNA ligase IV.";
RL   Curr. Biol. 7:588-598(1997).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH XRCC4; G22P1; G22P2 AND PRKDC.
RX   PubMed=10854421; DOI=10.1074/jbc.M000491200;
RA   Chen L., Trujillo K., Sung P., Tomkinson A.E.;
RT   "Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the
RT   DNA-dependent protein kinase.";
RL   J. Biol. Chem. 275:26196-26205(2000).
RN   [9]
RP   IDENTIFICATION IN A COMPLEX WITH G22P1; G22P2 AND PRKDC.
RX   PubMed=12547193; DOI=10.1016/S0022-2836(02)01328-1;
RA   Calsou P., Delteil C., Frit P., Drouet J., Salles B.;
RT   "Coordinated assembly of Ku and p460 subunits of the DNA-dependent
RT   protein kinase on DNA ends is necessary for XRCC4-ligase IV
RT   recruitment.";
RL   J. Mol. Biol. 326:93-103(2003).
RN   [10]
RP   INTERACTION WITH APLF.
RX   PubMed=17396150; DOI=10.1038/sj.emboj.7601663;
RA   Kanno S., Kuzuoka H., Sasao S., Hong Z., Lan L., Nakajima S.,
RA   Yasui A.;
RT   "A novel human AP endonuclease with conserved zinc-finger-like motifs
RT   involved in DNA strand break responses.";
RL   EMBO J. 26:2094-2103(2007).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   SUBUNIT.
RX   PubMed=25941166; DOI=10.1038/cdd.2015.22;
RA   Craxton A., Somers J., Munnur D., Jukes-Jones R., Cain K.,
RA   Malewicz M.;
RT   "XLS (c9orf142) is a new component of mammalian DNA double-stranded
RT   break repair.";
RL   Cell Death Differ. 22:890-897(2015).
RN   [13]
RP   SUBUNIT.
RX   PubMed=25670504; DOI=10.1038/ncomms7233;
RA   Xing M., Yang M., Huo W., Feng F., Wei L., Jiang W., Ning S., Yan Z.,
RA   Li W., Wang Q., Hou M., Dong C., Guo R., Gao G., Ji J., Zha S.,
RA   Lan L., Liang H., Xu D.;
RT   "Interactome analysis identifies a new paralogue of XRCC4 in non-
RT   homologous end joining DNA repair pathway.";
RL   Nat. Commun. 6:6233-6233(2015).
RN   [14]
RP   SUBUNIT.
RX   PubMed=25574025; DOI=10.1126/science.1261971;
RA   Ochi T., Blackford A.N., Coates J., Jhujh S., Mehmood S., Tamura N.,
RA   Travers J., Wu Q., Draviam V.M., Robinson C.V., Blundell T.L.,
RA   Jackson S.P.;
RT   "DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to
RT   promote DNA double-strand break repair.";
RL   Science 347:185-188(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 748-784 IN COMPLEX WITH
RP   XRCC4.
RX   PubMed=11702069; DOI=10.1038/nsb725;
RA   Sibanda B.L., Critchlow S.E., Begun J., Pei X.Y., Jackson S.P.,
RA   Blundell T.L., Pellegrini L.;
RT   "Crystal structure of an Xrcc4-DNA ligase IV complex.";
RL   Nat. Struct. Biol. 8:1015-1019(2001).
RN   [16]
RP   STRUCTURE BY NMR OF 654-759.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the first BRCT domain of human DNA ligase IV.";
RL   Submitted (DEC-2006) to the PDB data bank.
RN   [17]
RP   VARIANT LEUKEMIA HIS-278.
RX   PubMed=10395545; DOI=10.1016/S0960-9822(99)80311-X;
RA   Riballo E., Critchlow S.E., Teo S.-H., Doherty A.J., Priestley A.,
RA   Broughton B.C., Kysela B., Beamish H., Plowman N., Arlett C.F.,
RA   Lehmann A.R., Jackson S.P., Jeggo P.A.;
RT   "Identification of a defect in DNA ligase IV in a radiosensitive
RT   leukaemia patient.";
RL   Curr. Biol. 9:699-702(1999).
RN   [18]
RP   CHARACTERIZATION OF VARIANT HIS-278.
RX   PubMed=11349135; DOI=10.1074/jbc.M103866200;
RA   Riballo E., Doherty A.J., Dai Y., Stiff T., Oettinger M.A.,
RA   Jeggo P.A., Kysela B.;
RT   "Cellular and biochemical impact of a mutation in DNA ligase IV
RT   conferring clinical radiosensitivity.";
RL   J. Biol. Chem. 276:31124-31132(2001).
RN   [19]
RP   VARIANTS LIG4S HIS-278 AND GLU-469.
RX   PubMed=11779494; DOI=10.1016/S1097-2765(01)00408-7;
RA   O'Driscoll M., Cerosaletti K.M., Girard P.-M., Dai Y., Stumm M.,
RA   Kysela B., Hirsch B., Gennery A., Palmer S.E., Seidel J., Gatti R.A.,
RA   Varon R., Oettinger M.A., Neitzel H., Jeggo P.A., Concannon P.;
RT   "DNA ligase IV mutations identified in patients exhibiting
RT   developmental delay and immunodeficiency.";
RL   Mol. Cell 8:1175-1185(2001).
RN   [20]
RP   VARIANTS VAL-3 AND ILE-9, AND ASSOCIATION WITH RESISTANCE TO MULTIPLE
RP   MYELOMA.
RX   PubMed=12471202; DOI=10.1136/jmg.39.12.900;
RA   Roddam P.L., Rollinson S., O'Driscoll M., Jeggo P.A., Jack A.,
RA   Morgan G.J.;
RT   "Genetic variants of NHEJ DNA ligase IV can affect the risk of
RT   developing multiple myeloma, a tumour characterised by aberrant class
RT   switch recombination.";
RL   J. Med. Genet. 39:900-905(2002).
RN   [21]
RP   VARIANT RSSCID GLN-433 DEL.
RX   PubMed=16357942; DOI=10.1172/JCI26121;
RA   van der Burg M., van Veelen L.R., Verkaik N.S., Wiegant W.W.,
RA   Hartwig N.G., Barendregt B.H., Brugmans L., Raams A., Jaspers N.G.J.,
RA   Zdzienicka M.Z., van Dongen J.J.M., van Gent D.C.;
RT   "A new type of radiosensitive T-B-NK(+) severe combined
RT   immunodeficiency caused by a LIG4 mutation.";
RL   J. Clin. Invest. 116:137-145(2006).
RN   [22]
RP   VARIANT PRO-774.
RX   PubMed=25728776; DOI=10.1016/j.ajhg.2015.01.013;
RA   Murray J.E., van der Burg M., Ijspeert H., Carroll P., Wu Q., Ochi T.,
RA   Leitch A., Miller E.S., Kysela B., Jawad A., Bottani A., Brancati F.,
RA   Cappa M., Cormier-Daire V., Deshpande C., Faqeih E.A., Graham G.E.,
RA   Ranza E., Blundell T.L., Jackson A.P., Stewart G.S., Bicknell L.S.;
RT   "Mutations in the NHEJ component XRCC4 cause primordial dwarfism.";
RL   Am. J. Hum. Genet. 96:412-424(2015).
CC   -!- FUNCTION: Efficiently joins single-strand breaks in a double-
CC       stranded polydeoxynucleotide in an ATP-dependent reaction.
CC       Involved in DNA non-homologous end joining (NHEJ) required for
CC       double-strand break repair and V(D)J recombination. The LIG4-XRCC4
CC       complex is responsible for the NHEJ ligation step, and XRCC4
CC       enhances the joining activity of LIG4. Binding of the LIG4-XRCC4
CC       complex to DNA ends is dependent on the assembly of the DNA-
CC       dependent protein kinase complex DNA-PK to these DNA ends.
CC       {ECO:0000269|PubMed:10854421, ECO:0000269|PubMed:9809069}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + (deoxyribonucleotide)(n)-3'-hydroxyl + 5'-phospho-
CC         (deoxyribonucleotide)(m) = (deoxyribonucleotide)(n+m) + AMP +
CC         diphosphate.; EC=6.5.1.1; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10135};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts with XRCC4. The LIG4-XRCC4 complex has probably
CC       a 1:2 stoichiometry. The LIG4-XRCC4 complex associates in a DNA-
CC       dependent manner with the DNA-PK complex composed of PRKDC,
CC       XRCC6/Ku70 and XRCC5/Ku86 to form the core non-homologous end
CC       joining (NHEJ) complex. Additional components of the NHEJ complex
CC       include NHEJ1/XLF and PAXX. Interacts with APLF.
CC       {ECO:0000269|PubMed:10854421, ECO:0000269|PubMed:11702069,
CC       ECO:0000269|PubMed:12547193, ECO:0000269|PubMed:17396150,
CC       ECO:0000269|PubMed:25574025, ECO:0000269|PubMed:25670504,
CC       ECO:0000269|PubMed:25941166, ECO:0000269|PubMed:9259561,
CC       ECO:0000269|PubMed:9809069}.
CC   -!- INTERACTION:
CC       Q8IW19:APLF; NbExp=2; IntAct=EBI-847896, EBI-1256044;
CC       Q96SD1:DCLRE1C; NbExp=16; IntAct=EBI-847896, EBI-11694104;
CC       Q9H9Q4:NHEJ1; NbExp=4; IntAct=EBI-847896, EBI-847807;
CC       Q13426:XRCC4; NbExp=13; IntAct=EBI-847896, EBI-717592;
CC       Q13426-2:XRCC4; NbExp=11; IntAct=EBI-847896, EBI-15891375;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Testis, thymus, prostate and heart.
CC   -!- DISEASE: LIG4 syndrome (LIG4S) [MIM:606593]: Characterized by
CC       immunodeficiency and developmental and growth delay. Patients
CC       display unusual facial features, microcephaly, growth and/or
CC       developmental delay, pancytopenia, and various skin abnormalities.
CC       {ECO:0000269|PubMed:11779494}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Severe combined immunodeficiency autosomal recessive T-
CC       cell-negative/B-cell-negative/NK-cell-positive with sensitivity to
CC       ionizing radiation (RSSCID) [MIM:602450]: A form of severe
CC       combined immunodeficiency, a genetically and clinically
CC       heterogeneous group of rare congenital disorders characterized by
CC       impairment of both humoral and cell-mediated immunity, leukopenia,
CC       and low or absent antibody levels. Patients present in infancy
CC       with recurrent, persistent infections by opportunistic organisms.
CC       The common characteristic of all types of SCID is absence of T-
CC       cell-mediated cellular immunity due to a defect in T-cell
CC       development. Individuals affected by RS-SCID show defects in the
CC       DNA repair machinery necessary for coding joint formation and the
CC       completion of V(D)J recombination. A subset of cells from such
CC       patients show increased radiosensitivity.
CC       {ECO:0000269|PubMed:16357942}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ATP-dependent DNA ligase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL77435.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAA58467.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=LIG4base; Note=LIG4 mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/LIG4base/";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/lig4/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=DNA ligase entry;
CC       URL="https://en.wikipedia.org/wiki/DNA_ligase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; X83441; CAA58467.1; ALT_INIT; mRNA.
DR   EMBL; AF479264; AAL77435.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL157762; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC037491; AAH37491.1; -; mRNA.
DR   CCDS; CCDS9508.1; -.
DR   PIR; I37079; I37079.
DR   RefSeq; NP_001091738.1; NM_001098268.1.
DR   RefSeq; NP_001317524.1; NM_001330595.1.
DR   RefSeq; NP_002303.2; NM_002312.3.
DR   RefSeq; NP_996820.1; NM_206937.1.
DR   RefSeq; XP_005254113.1; XM_005254056.1.
DR   RefSeq; XP_005254114.1; XM_005254057.4.
DR   RefSeq; XP_005254115.1; XM_005254058.3.
DR   RefSeq; XP_006720014.1; XM_006719951.3.
DR   RefSeq; XP_006720015.1; XM_006719952.1.
DR   RefSeq; XP_011519393.1; XM_011521091.2.
DR   RefSeq; XP_011519394.1; XM_011521092.2.
DR   RefSeq; XP_016876058.1; XM_017020569.1.
DR   RefSeq; XP_016876059.1; XM_017020570.1.
DR   RefSeq; XP_016876060.1; XM_017020571.1.
DR   RefSeq; XP_016876062.1; XM_017020573.1.
DR   UniGene; Hs.166091; -.
DR   PDB; 1IK9; X-ray; 2.30 A; C=748-784.
DR   PDB; 2E2W; NMR; -; A=654-759.
DR   PDB; 3II6; X-ray; 2.40 A; X/Y=654-911.
DR   PDB; 3VNN; X-ray; 2.90 A; A=268-406.
DR   PDB; 3W1B; X-ray; 2.40 A; A=1-609.
DR   PDB; 3W1G; X-ray; 2.55 A; A=1-609.
DR   PDB; 3W5O; X-ray; 2.84 A; A/B=1-609.
DR   PDB; 4HTO; X-ray; 2.81 A; A=1-240.
DR   PDB; 4HTP; X-ray; 2.25 A; A/B=1-240.
DR   PDB; 6BKF; X-ray; 3.25 A; A=1-620.
DR   PDB; 6BKG; X-ray; 2.40 A; A=1-620.
DR   PDBsum; 1IK9; -.
DR   PDBsum; 2E2W; -.
DR   PDBsum; 3II6; -.
DR   PDBsum; 3VNN; -.
DR   PDBsum; 3W1B; -.
DR   PDBsum; 3W1G; -.
DR   PDBsum; 3W5O; -.
DR   PDBsum; 4HTO; -.
DR   PDBsum; 4HTP; -.
DR   PDBsum; 6BKF; -.
DR   PDBsum; 6BKG; -.
DR   ProteinModelPortal; P49917; -.
DR   SMR; P49917; -.
DR   BioGrid; 110169; 132.
DR   CORUM; P49917; -.
DR   DIP; DIP-37958N; -.
DR   IntAct; P49917; 11.
DR   MINT; P49917; -.
DR   STRING; 9606.ENSP00000349393; -.
DR   iPTMnet; P49917; -.
DR   PhosphoSitePlus; P49917; -.
DR   BioMuta; LIG4; -.
DR   DMDM; 88911290; -.
DR   EPD; P49917; -.
DR   jPOST; P49917; -.
DR   MaxQB; P49917; -.
DR   PaxDb; P49917; -.
DR   PeptideAtlas; P49917; -.
DR   PRIDE; P49917; -.
DR   ProteomicsDB; 56183; -.
DR   DNASU; 3981; -.
DR   Ensembl; ENST00000356922; ENSP00000349393; ENSG00000174405.
DR   Ensembl; ENST00000405925; ENSP00000385955; ENSG00000174405.
DR   Ensembl; ENST00000442234; ENSP00000402030; ENSG00000174405.
DR   Ensembl; ENST00000611712; ENSP00000484288; ENSG00000174405.
DR   GeneID; 3981; -.
DR   KEGG; hsa:3981; -.
DR   UCSC; uc001vqn.4; human.
DR   CTD; 3981; -.
DR   DisGeNET; 3981; -.
DR   EuPathDB; HostDB:ENSG00000174405.13; -.
DR   GeneCards; LIG4; -.
DR   HGNC; HGNC:6601; LIG4.
DR   HPA; HPA001334; -.
DR   HPA; HPA057325; -.
DR   MalaCards; LIG4; -.
DR   MIM; 601837; gene.
DR   MIM; 602450; phenotype.
DR   MIM; 606593; phenotype.
DR   neXtProt; NX_P49917; -.
DR   OpenTargets; ENSG00000174405; -.
DR   Orphanet; 235; Dubowitz syndrome.
DR   Orphanet; 99812; LIG4 syndrome.
DR   Orphanet; 39041; Omenn syndrome.
DR   PharmGKB; PA30375; -.
DR   eggNOG; KOG0966; Eukaryota.
DR   eggNOG; COG1793; LUCA.
DR   GeneTree; ENSGT00860000133881; -.
DR   HOGENOM; HOG000007831; -.
DR   HOVERGEN; HBG005516; -.
DR   InParanoid; P49917; -.
DR   KO; K10777; -.
DR   OMA; HMCPSTK; -.
DR   OrthoDB; 274264at2759; -.
DR   PhylomeDB; P49917; -.
DR   TreeFam; TF312980; -.
DR   BRENDA; 6.5.1.1; 2681.
DR   Reactome; R-HSA-164843; 2-LTR circle formation.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   SignaLink; P49917; -.
DR   SIGNOR; P49917; -.
DR   ChiTaRS; LIG4; human.
DR   EvolutionaryTrace; P49917; -.
DR   GeneWiki; LIG4; -.
DR   GenomeRNAi; 3981; -.
DR   PRO; PR:P49917; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000174405; Expressed in 210 organ(s), highest expression level in bone marrow.
DR   CleanEx; HS_LIG4; -.
DR   ExpressionAtlas; P49917; baseline and differential.
DR   Genevisible; P49917; HS.
DR   GO; GO:0000793; C:condensed chromosome; IDA:UniProtKB.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA.
DR   GO; GO:0032807; C:DNA ligase IV complex; IMP:UniProtKB.
DR   GO; GO:0005958; C:DNA-dependent protein kinase-DNA ligase 4 complex; IDA:MGI.
DR   GO; GO:0070419; C:nonhomologous end joining complex; IDA:UniProtKB.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IC:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003910; F:DNA ligase (ATP) activity; IDA:UniProtKB.
DR   GO; GO:0003909; F:DNA ligase activity; IDA:UniProtKB.
DR   GO; GO:0016874; F:ligase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008283; P:cell proliferation; ISS:UniProtKB.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; IGI:UniProtKB.
DR   GO; GO:0071285; P:cellular response to lithium ion; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; ISS:UniProtKB.
DR   GO; GO:0051276; P:chromosome organization; ISS:UniProtKB.
DR   GO; GO:0071897; P:DNA biosynthetic process; IEA:InterPro.
DR   GO; GO:0006266; P:DNA ligation; IDA:UniProtKB.
DR   GO; GO:0051102; P:DNA ligation involved in DNA recombination; ISS:UniProtKB.
DR   GO; GO:0051103; P:DNA ligation involved in DNA repair; IDA:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0006302; P:double-strand break repair; IDA:UniProtKB.
DR   GO; GO:0097680; P:double-strand break repair via classical nonhomologous end joining; IMP:BHF-UCL.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; IDA:UniProtKB.
DR   GO; GO:0075713; P:establishment of integrated proviral latency; TAS:Reactome.
DR   GO; GO:0033152; P:immunoglobulin V(D)J recombination; IBA:GO_Central.
DR   GO; GO:0001701; P:in utero embryonic development; ISS:UniProtKB.
DR   GO; GO:0045190; P:isotype switching; ISS:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0051402; P:neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; IDA:UniProtKB.
DR   GO; GO:2001252; P:positive regulation of chromosome organization; IMP:BHF-UCL.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; ISS:UniProtKB.
DR   GO; GO:0050769; P:positive regulation of neurogenesis; ISS:UniProtKB.
DR   GO; GO:0002328; P:pro-B cell differentiation; ISS:UniProtKB.
DR   GO; GO:0010332; P:response to gamma radiation; ISS:UniProtKB.
DR   GO; GO:0010165; P:response to X-ray; IMP:UniProtKB.
DR   GO; GO:0000012; P:single strand break repair; IDA:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISS:UniProtKB.
DR   GO; GO:0033077; P:T cell differentiation in thymus; ISS:UniProtKB.
DR   GO; GO:0033153; P:T cell receptor V(D)J recombination; ISS:UniProtKB.
DR   GO; GO:0033151; P:V(D)J recombination; IDA:UniProtKB.
DR   CDD; cd00027; BRCT; 2.
DR   Gene3D; 1.10.3260.10; -; 1.
DR   Gene3D; 3.40.50.10190; -; 2.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   InterPro; IPR000977; DNA_ligase_ATP-dep.
DR   InterPro; IPR012309; DNA_ligase_ATP-dep_C.
DR   InterPro; IPR012310; DNA_ligase_ATP-dep_cent.
DR   InterPro; IPR016059; DNA_ligase_ATP-dep_CS.
DR   InterPro; IPR012308; DNA_ligase_ATP-dep_N.
DR   InterPro; IPR021536; DNA_ligase_IV_dom.
DR   InterPro; IPR036599; DNA_ligase_N_sf.
DR   InterPro; IPR029710; LIG4.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   PANTHER; PTHR10459:SF7; PTHR10459:SF7; 1.
DR   Pfam; PF00533; BRCT; 2.
DR   Pfam; PF04679; DNA_ligase_A_C; 1.
DR   Pfam; PF01068; DNA_ligase_A_M; 1.
DR   Pfam; PF04675; DNA_ligase_A_N; 1.
DR   Pfam; PF11411; DNA_ligase_IV; 1.
DR   SMART; SM00292; BRCT; 2.
DR   SUPFAM; SSF117018; SSF117018; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   SUPFAM; SSF52113; SSF52113; 2.
DR   TIGRFAMs; TIGR00574; dnl1; 1.
DR   PROSITE; PS50172; BRCT; 2.
DR   PROSITE; PS00697; DNA_LIGASE_A1; 1.
DR   PROSITE; PS00333; DNA_LIGASE_A2; 1.
DR   PROSITE; PS50160; DNA_LIGASE_A3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell cycle; Cell division;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   DNA damage; DNA recombination; DNA repair; DNA replication; Ligase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Polymorphism;
KW   Reference proteome; Repeat; SCID.
FT   CHAIN         1    911       DNA ligase 4.
FT                                /FTId=PRO_0000059576.
FT   DOMAIN      654    743       BRCT 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   DOMAIN      808    911       BRCT 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00033}.
FT   ACT_SITE    273    273       N6-AMP-lysine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10135}.
FT   METAL       331    331       Magnesium 1. {ECO:0000255}.
FT   METAL       427    427       Magnesium 2. {ECO:0000255}.
FT   BINDING     271    271       ATP. {ECO:0000250}.
FT   BINDING     278    278       ATP. {ECO:0000250}.
FT   BINDING     293    293       ATP. {ECO:0000250}.
FT   BINDING     432    432       ATP. {ECO:0000250}.
FT   BINDING     443    443       ATP. {ECO:0000250}.
FT   BINDING     449    449       ATP. {ECO:0000250}.
FT   VARIANT       3      3       A -> V (associated with resistance to
FT                                multiple myeloma; dbSNP:rs1805389).
FT                                {ECO:0000269|PubMed:12471202}.
FT                                /FTId=VAR_029352.
FT   VARIANT       9      9       T -> I (associated with resistance to
FT                                multiple myeloma; dbSNP:rs1805388).
FT                                {ECO:0000269|PubMed:12471202}.
FT                                /FTId=VAR_033884.
FT   VARIANT      62     62       D -> H (in dbSNP:rs3093763).
FT                                /FTId=VAR_029353.
FT   VARIANT     231    231       P -> S (in dbSNP:rs3093765).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_018808.
FT   VARIANT     278    278       R -> H (in LIG4S and leukemia; impairs
FT                                activity; dbSNP:rs104894421).
FT                                {ECO:0000269|PubMed:10395545,
FT                                ECO:0000269|PubMed:11349135,
FT                                ECO:0000269|PubMed:11779494}.
FT                                /FTId=VAR_012774.
FT   VARIANT     433    433       Missing (in RSSCID).
FT                                {ECO:0000269|PubMed:16357942}.
FT                                /FTId=VAR_044123.
FT   VARIANT     461    461       E -> G (in dbSNP:rs2232640).
FT                                /FTId=VAR_044124.
FT   VARIANT     469    469       G -> E (in LIG4S; dbSNP:rs104894420).
FT                                {ECO:0000269|PubMed:11779494}.
FT                                /FTId=VAR_012775.
FT   VARIANT     539    539       L -> F (in dbSNP:rs3742212).
FT                                /FTId=VAR_016771.
FT   VARIANT     658    658       I -> V (in dbSNP:rs2232641).
FT                                /FTId=VAR_016772.
FT   VARIANT     774    774       L -> P (found in a patient with
FT                                microcephalic primordial dwarfism;
FT                                unknown pathological significance;
FT                                dbSNP:rs1060499662).
FT                                {ECO:0000269|PubMed:25728776}.
FT                                /FTId=VAR_075826.
FT   VARIANT     857    857       A -> T (in dbSNP:rs2232642).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_016773.
FT   CONFLICT    246    246       F -> S (in Ref. 1; CAA58467).
FT                                {ECO:0000305}.
FT   HELIX        10     12       {ECO:0000244|PDB:4HTP}.
FT   HELIX        16     28       {ECO:0000244|PDB:4HTP}.
FT   HELIX        32     53       {ECO:0000244|PDB:4HTP}.
FT   TURN         54     56       {ECO:0000244|PDB:4HTP}.
FT   HELIX        65     71       {ECO:0000244|PDB:4HTP}.
FT   HELIX        73     75       {ECO:0000244|PDB:4HTP}.
FT   HELIX        86     96       {ECO:0000244|PDB:4HTP}.
FT   HELIX       104    110       {ECO:0000244|PDB:4HTP}.
FT   TURN        111    113       {ECO:0000244|PDB:6BKG}.
FT   HELIX       125    133       {ECO:0000244|PDB:4HTP}.
FT   TURN        134    136       {ECO:0000244|PDB:3W1B}.
FT   HELIX       145    160       {ECO:0000244|PDB:4HTP}.
FT   HELIX       164    176       {ECO:0000244|PDB:4HTP}.
FT   HELIX       180    191       {ECO:0000244|PDB:4HTP}.
FT   HELIX       200    207       {ECO:0000244|PDB:4HTP}.
FT   HELIX       211    218       {ECO:0000244|PDB:4HTP}.
FT   HELIX       221    227       {ECO:0000244|PDB:4HTP}.
FT   STRAND      230    232       {ECO:0000244|PDB:6BKF}.
FT   STRAND      250    253       {ECO:0000244|PDB:3W1B}.
FT   HELIX       256    258       {ECO:0000244|PDB:3W1B}.
FT   HELIX       259    262       {ECO:0000244|PDB:3W1B}.
FT   TURN        263    265       {ECO:0000244|PDB:3W1B}.
FT   STRAND      268    272       {ECO:0000244|PDB:3W1B}.
FT   STRAND      276    284       {ECO:0000244|PDB:3W1B}.
FT   STRAND      287    292       {ECO:0000244|PDB:3W1B}.
FT   HELIX       299    302       {ECO:0000244|PDB:3W1B}.
FT   STRAND      308    311       {ECO:0000244|PDB:3W1B}.
FT   HELIX       312    315       {ECO:0000244|PDB:3W1B}.
FT   HELIX       316    318       {ECO:0000244|PDB:3W1B}.
FT   STRAND      324    336       {ECO:0000244|PDB:3W1B}.
FT   TURN        337    340       {ECO:0000244|PDB:3W1B}.
FT   STRAND      341    343       {ECO:0000244|PDB:3W1B}.
FT   HELIX       351    356       {ECO:0000244|PDB:3W1B}.
FT   STRAND      359    372       {ECO:0000244|PDB:3W1B}.
FT   STRAND      378    380       {ECO:0000244|PDB:3VNN}.
FT   HELIX       382    392       {ECO:0000244|PDB:3W1B}.
FT   TURN        397    399       {ECO:0000244|PDB:3W1B}.
FT   STRAND      400    402       {ECO:0000244|PDB:3W1B}.
FT   STRAND      405    408       {ECO:0000244|PDB:3W1B}.
FT   HELIX       411    423       {ECO:0000244|PDB:3W1B}.
FT   STRAND      429    432       {ECO:0000244|PDB:3W1B}.
FT   STRAND      443    450       {ECO:0000244|PDB:3W1B}.
FT   HELIX       452    454       {ECO:0000244|PDB:6BKG}.
FT   HELIX       458    460       {ECO:0000244|PDB:3W1B}.
FT   STRAND      462    471       {ECO:0000244|PDB:3W1B}.
FT   HELIX       474    478       {ECO:0000244|PDB:3W1B}.
FT   STRAND      479    488       {ECO:0000244|PDB:3W1B}.
FT   STRAND      500    507       {ECO:0000244|PDB:3W1B}.
FT   HELIX       513    522       {ECO:0000244|PDB:3W1B}.
FT   HELIX       523    525       {ECO:0000244|PDB:3W1B}.
FT   STRAND      536    539       {ECO:0000244|PDB:6BKG}.
FT   STRAND      546    548       {ECO:0000244|PDB:3W1B}.
FT   HELIX       551    553       {ECO:0000244|PDB:3W1B}.
FT   STRAND      556    560       {ECO:0000244|PDB:3W1B}.
FT   STRAND      562    566       {ECO:0000244|PDB:3W1B}.
FT   STRAND      568    570       {ECO:0000244|PDB:3W1B}.
FT   STRAND      573    578       {ECO:0000244|PDB:3W1B}.
FT   STRAND      580    584       {ECO:0000244|PDB:3W1B}.
FT   STRAND      586    588       {ECO:0000244|PDB:6BKF}.
FT   HELIX       590    592       {ECO:0000244|PDB:3W1B}.
FT   HELIX       596    603       {ECO:0000244|PDB:3W1B}.
FT   TURN        606    608       {ECO:0000244|PDB:6BKG}.
FT   STRAND      609    611       {ECO:0000244|PDB:6BKG}.
FT   TURN        658    661       {ECO:0000244|PDB:3II6}.
FT   STRAND      663    666       {ECO:0000244|PDB:3II6}.
FT   STRAND      671    673       {ECO:0000244|PDB:2E2W}.
FT   HELIX       675    684       {ECO:0000244|PDB:3II6}.
FT   STRAND      687    692       {ECO:0000244|PDB:2E2W}.
FT   STRAND      697    701       {ECO:0000244|PDB:3II6}.
FT   HELIX       707    714       {ECO:0000244|PDB:3II6}.
FT   HELIX       723    732       {ECO:0000244|PDB:3II6}.
FT   HELIX       740    742       {ECO:0000244|PDB:3II6}.
FT   STRAND      743    745       {ECO:0000244|PDB:3II6}.
FT   HELIX       748    753       {ECO:0000244|PDB:3II6}.
FT   TURN        754    757       {ECO:0000244|PDB:3II6}.
FT   STRAND      764    767       {ECO:0000244|PDB:1IK9}.
FT   HELIX       771    779       {ECO:0000244|PDB:1IK9}.
FT   HELIX       789    802       {ECO:0000244|PDB:3II6}.
FT   HELIX       809    811       {ECO:0000244|PDB:3II6}.
FT   TURN        812    815       {ECO:0000244|PDB:3II6}.
FT   STRAND      817    820       {ECO:0000244|PDB:3II6}.
FT   STRAND      823    825       {ECO:0000244|PDB:3II6}.
FT   HELIX       829    831       {ECO:0000244|PDB:3II6}.
FT   HELIX       837    847       {ECO:0000244|PDB:3II6}.
FT   STRAND      851    855       {ECO:0000244|PDB:3II6}.
FT   STRAND      862    865       {ECO:0000244|PDB:3II6}.
FT   HELIX       872    880       {ECO:0000244|PDB:3II6}.
FT   STRAND      887    890       {ECO:0000244|PDB:3II6}.
FT   HELIX       892    899       {ECO:0000244|PDB:3II6}.
FT   HELIX       906    908       {ECO:0000244|PDB:3II6}.
SQ   SEQUENCE   911 AA;  103971 MW;  2122813E1EFA63B9 CRC64;
     MAASQTSQTV ASHVPFADLC STLERIQKSK GRAEKIRHFR EFLDSWRKFH DALHKNHKDV
     TDSFYPAMRL ILPQLERERM AYGIKETMLA KLYIELLNLP RDGKDALKLL NYRTPTGTHG
     DAGDFAMIAY FVLKPRCLQK GSLTIQQVND LLDSIASNNS AKRKDLIKKS LLQLITQSSA
     LEQKWLIRMI IKDLKLGVSQ QTIFSVFHND AAELHNVTTD LEKVCRQLHD PSVGLSDISI
     TLFSAFKPML AAIADIEHIE KDMKHQSFYI ETKLDGERMQ MHKDGDVYKY FSRNGYNYTD
     QFGASPTEGS LTPFIHNAFK ADIQICILDG EMMAYNPNTQ TFMQKGTKFD IKRMVEDSDL
     QTCYCVFDVL MVNNKKLGHE TLRKRYEILS SIFTPIPGRI EIVQKTQAHT KNEVIDALNE
     AIDKREEGIM VKQPLSIYKP DKRGEGWLKI KPEYVSGLMD ELDILIVGGY WGKGSRGGMM
     SHFLCAVAEK PPPGEKPSVF HTLSRVGSGC TMKELYDLGL KLAKYWKPFH RKAPPSSILC
     GTEKPEVYIE PCNSVIVQIK AAEIVPSDMY KTGCTLRFPR IEKIRDDKEW HECMTLDDLE
     QLRGKASGKL ASKHLYIGGD DEPQEKKRKA APKMKKVIGI IEHLKAPNLT NVNKISNIFE
     DVEFCVMSGT DSQPKPDLEN RIAEFGGYIV QNPGPDTYCV IAGSENIRVK NIILSNKHDV
     VKPAWLLECF KTKSFVPWQP RFMIHMCPST KEHFAREYDC YGDSYFIDTD LNQLKEVFSG
     IKNSNEQTPE EMASLIADLE YRYSWDCSPL SMFRRHTVYL DSYAVINDLS TKNEGTRLAI
     KALELRFHGA KVVSCLAEGV SHVIIGEDHS RVADFKAFRR TFKRKFKILK ESWVTDSIDK
     CELQEENQYL I
//
ID   ERER_HUMAN              Reviewed;         511 AA.
AC   xx; ss; dd; dd; rr;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   16-JAN-2019, entry version 130.
DE   RecName: Full=Aprataxin and PNK-like factor;
DE            EC=4.2.99.18;
DE   AltName: Full=Apurinic-apyrimidinic endonuclease APLF;
DE   AltName: Full=PNK and APTX-like FHA domain-containing protein;
DE   AltName: Full=XRCC1-interacting protein 1;
GN   Name=APLF; Synonyms=C2orf13, PALF, XIP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,

